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ABSTRACT
MARGINAL NONPARAMETRIC INFERENCE FOR WAITING TIMES IN
MULTISTAGE MODELS: HYPOTHESIS TESTING AND REGRESSION
Douglas J. Lorenz
May 14, 2011

Marginal inference for waiting times in multi-stage time-to-event models is
complicated by right censoring of observations as well as the prior history of events in the
model. In general, complications arise due to the evolution of the censoring process in so
called "calendar time", contrasted with the evolution of the waiting time process
conditional upon entry into a given stage. Developments in inference for survival data
under dependent censoring have been extended to the multi-stage framework, and
non parametric estimators for the cumulative hazard function and survival function for
waiting times analogous of the classical Nelson-Aalen and Kaplan-Meier estimators for
survival data have been developed. These estimators were derived under the principle of
weighting the basic at-risk and event counting processes by the inverse probability of
censoring. We extend this concept to K-sample hypothesis testing and non parametric
regression, and define test statistics and regression coefficient estimators analogous to the
log-rank test and Aalen's nonparametric linear regression estimators for survival data. We
examine the asymptotic distribution of these statistics, and justify their use via simulation
studies and analyses of real data sets.
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CHAPTER I
INTRODUCTION
Multi-stage models provide a convenient framework for analyzing event history data,
in which individuals proceed through a sequence of events in time. Multi-stage models
generalize traditional survival or time-to-event data, in that individuals potentially
experience a sequence of events rather than proceeding from a root stage to a single
terminal au::;uruing stage. The events of multi-stage models are represented as stages and
the occurrence of the events as transitions between the stages. Survival data, wherein
individuals start at a root stage and progress to a single absorbing stage, provide the
simplest example and are termed irreversible two-stage models in the nomenclature of
multi-stage models. Other simple examples of multi-stage models include the competing
risks model, in which individuals progress from a root stage to any of a set of absorbing
stages. In biomedical applications, these states are generally referred to as an "alive" state
(the root stage) and "death by cause X" (the set of absorbing stages). The three-stage
illness-death model provides another simple example. Individuals progress from a root
state ("well") to an intermediary "illness" state and finally to an absorbing "dead" state.
The multi-stage framework is suitably flexible to allow far more complex networks of
stages. For example, the topology of the illness-death model can be made more complex by
allowing direct transitions from the alive state to the dead state or by allowing transitions
from the illness state back to the well state in an unlimited fashion.
The analysis of multi-stage data, also referred to as failure time data, is frequently
complicated by right censoring, the partial observation of the progression through stages in
the model caused by the exit of an experimental unit from observation before the full
sequence of events has occurred. For simple survival data, traditional inferential procedures
such as point and interval estimates of the cumulative hazard and survival functions,
coefficients from parametric and semi-parametric regression models, and hypothesis test
statistics, generally assume the statistical independence of survival times and censoring
times. Practically speaking, this independence assumption provides reasonable assurance
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that what an experimenter observes - the right-censored survival times - does not
substantially differ from what actually occurs - the uncensored survival times - and that
inference based on right-censored data will correspond with inference based on the
uncensored data. When the independence of right-censoring and survival times cannot be
safely assumed, inferential procedures requiring the independence assumption can be
biased. For example, suppose that in an experiment censoring times and survival times are
negatively correlated. Short survival times are then associated with long censoring times
and are more likely to be fully observed. Conversely, long survival times are associated
with short censoring times and more likely to be partially observed (censored). An
estimator of the cumulative hazard function requiring the independence assumption would
then overestimate the true cumulative hazard, as the fully observed survival times would
tend to be shorter, indicating greater hazard, and the censored survival times would tend
to be longer.
From an analytical perspective, there are many areas of interest for data derived
from a multi-stage model - the estimation of stage-to-stage transition probabilities, hazard
and survival functions for exit from a given stage, hazard and survival functions from a
given stage to a particular subsequent stage, stage-occupation probabilities, etc. Presently,
we will focus on the marginal analysis of waiting times for secondary, transient stages in a
multi-stage model, defined as the time from entry into a given stage until stage exit and
also referred to as sojourn or gap times. Waiting times are conceptually similar to survival
times, in that one observes the time until a given event (stage exit) occurs, with the caveat
that the time to stage exit is observed conditional upon entry into the given stage. Given
this similarity, a naive approach to a marginal analysis of waiting times would be to apply
survival data methods - the Nelson-Aalen estimator of the cumulative hazard function or
Kaplan-Meier estimator of the survival function - on the set of individuals observed to
enter a given stage, under the assumption that right censoring times are independent of
stage transition times. However, such an independence assumption is insufficient to
guarantee the applicability of methods for survival data to waiting times from multi-stage
models. One must additionally assume the independence of stage transition times, the
so-called semi-Markov property.
A heuristic argument can be used to demonstrate the additional need for the
semi-Markov property. Let T and U denote the true entry and exit times for a given
transient state in a multi-stage model, and let C denote the right-censoring time. Much of
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the added complexity of analyzing multi-stage data stems from the fact that the waiting
time process U - T evolves conditional upon entry into the given stage (i.e. after random
time T), whereas the censoring process evolves in "calendar time", the time from which
observation of the multi-stage model commences (i.e. "time 0"). In a marginal treatment
of waiting times, we are in effect interested only in what happens after entry into the given
stage, (i.e.) what happens after time T. Hence, the waiting time process, U - T, is
censored not by C but by the censoring time after entry into the given stage, C - T.
Assuming the independence of censoring and waiting times for a given stage in a marginal
analysis thus corresponds to assuming the independence of U - T and C - T. From this, it
is easily seen that both independent censoring (U, T J.. C) and the semi-Markov property
(U J.. T) are required. Hence, even when the waiting time U - T can be assumed to be

independent of the censoring time C in a multi-stage model, dependent censoring can be
"induced" by dependence between U and T. This heuristic argument is not meant to imply
that what happens before time T is completely irrelevant to the marginal analysis of
waiting times; note that it is possible for individuals to be censored prior to entry into the
stage of interest (C - T < 0). Survival data methods applied to waiting times from a
multi-stage model would be necessarily carried out on the set of individuals observed to
enter a given stage, completely ignoring individuals censored prior to stage entry that may
have entered the given stage and posing an additional problem for their applicability.
In practice, the semi-Markov property can be restrictive and implausible for
multi-stage models and in the marginal analysis of waiting times. Inference for survival
data under dependent censoring and waiting times from multi-stage models under
dependent censoring and/or transition times has generally focused on adjusting for
dependent censoring in some capacity. A method that has received particular focus is
known as inverse probability of censoring weighting (IPCW), first introduced by Robins and
Rotnitsky [39] in the analysis of survival data. To describe IPCW, we first note that many
statistics for survival data are functions of two counting processes evolving in time, (1) the
event counting process, which counts the number of events of interest (failures) that have
occurred up to a given time, and (2) the at-risk counting process, which counts the number
of experimental units at risk for the event of interest at a given time. (The counting process
formulation for the analysis of survival data was first proposed by Aalen [1] in a landmark
paper, and has received considerable attention since.) The IPCW method operates by
weighting these basic counting process by the inverse probability of censoring, thereby

3

weighting the statistics that are functions of these counting processes. Thus, observations
more/less likely to be censored are given greater/lower weight, in turn adjusting for the
potential bias introduced by dependent censoring. The IPCW method has root in the
Horvitz-Thompson estimator [19], a popular method in the analysis of sample surveys,
which weights observations by the inverse probability of an observation being selected.
The IPCW method has been used to develop dependent-censoring analogues of
several regular estimators for survival data. Robins and Rotnitsky [40J developed coefficient
estimators for semi parametric regression models under dependent censoring analogous to
well-known estimators from the Cox proportional hazards model [9J. Satten and Datta [41]
demonstrated that the Kaplan-Meier estimator [24] of the survival function had
representation as an IPCW average, and Satten, Datta and Robins [42, 43J developed
estimators of the cumulative hazard and survival functIOns under dependent censoring as
analogues of the classical Nelson-Aalen [1, 36J and Kaplan-Meier estimators. Robins and
Finkelstein [38] adapted IPCW semi parametric regression estimators to develop IPCW
Kaplan-Meier estimators and score tests for two group comparisons. We note that in this
paper, IPCW was used to correct not only for dependent censoring but also non-compliance
with a given therapeutic regimen in a two-arm study of AIDS treatment. Cain and Cole [7J
extended these results to correct time-varying non-compliance with treatment. Howe, et al
[21] have noted limitations in the estimation of survival via IPCW in the presence of strong
selection bias. Recently, Datta, et al [IOJ developed a broad theory for IPCW U-statistics
with applications to testing problems for right-censored data. We note that weighted
estimation for survival data was first considered by Koul, Susarla, and Van Ryzin [28], who
developed weighted OLS regression estimators for randomly right censored survival data.
Weighting by the inverse probability of censoring has also been used in the analysis
of multi-stage data. The IPCW approach has previously been applied to multi-stage data
to develop estimators of transition hazards and stage occupation probabilities [11, 13J and
to prove the validity of an Aalen-Johansen-type estimator [5J of the integrated transition
hazard matrix for non-Markov models [12]. Gunnes, Borgan, and Aalen [18] conducted a
detailed examination of the Aalen-Johansen and Datta-Satten estimators of stage
occupation probabilities, and noted that the Datta-Satten estimator remained
approximately unbiased while the Aalen-Johansen estimator under- or over-estimated stage
occupation probabilities based on dependent censoring patterns. The authors did note that
in their simulations, differences between the Datta-Satten and Aalen-Johansen estimators
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were of practical importance only under very selective censoring mechanisms. For the
analysis of waiting times from a multi-stage model, Matsuyama and Yamaguchi [35]
introduced IPCW estimators of marginal survival times for dependent competing risks.
These estimators were a special case of survival function estimators for waiting times from
general multi-stage models, which were developed by Satten and Datta [44] as IPCW
analogues of the Nelson-Aalen and Kaplan-Meier estimators for survival data. The
application of IPCW methods to multi-stage data have not been limited to being marginal
in scope. Lahkal-Chaeib, Cook and Lin [29] examined the joint distribution of waiting
times from multi-stage models, and in particular developed nonparametric estimators for
correlations between waiting times from consecutive states based on Kendall's

T.

We briefly note that the IPCW method does not represent the only method for
adjusting for dependent censoring for survival data or dependent transition times in a
multi-stage model, nor the only method for reweighting to correct for bias. Wang and
Wells [47] and Lin, Sun, and Ying [32] introduced marginal estimators for waiting times in
the transient (i.e. second) stage in a three-stage illness death model. Huang [22] and
Strawderman [46] separately developed accelerated waiting time models for multi-stage data
as natural extensions of the accelerated failure time model for survival data. Schaubel and
Cai [45] proposed regression models for the waiting time hazard function (termed gap time
hazard by the authors). In each of these papers, the authors arrived at model estimators
through appropriate reweightings of regular estimating equations for survival data.
In what follows, we employ the principle of IPCW to develop K-sample test statistics
and nonparametric regression estimators for waiting times from a multi-stage model. The
test statistics we introduce serve as analogues of the Fleming-Harrington [16] class of
K-group tests for survival data, which includes the popular log-rank test [34]. Hypothesis
testing under dependent censoring for survival data has previously been considered by Lin,
Robins, and Wei [31], who introduced a two-sample test statistic by considering a bivariate
location-shift model with unspecified underlying distribution for the failure and censoring
times. Lin and Ying [33] proposed weighted log-rank and Pepe-Fleming [37] type statistics
for waiting times involving reweighting and conditioning on threshold values for stage entry
times. Fan and Datta [15] developed IPCW Mann-Whitney statistics for two-group
comparisons of waiting times from multi-stage models. Additionally, the asymptotic theory
for the regression models mentioned in the previous paragraphs can provide K -sample
hypothesis test statistics when the model covariate is K -categorical. As noted above,
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Robins and Finkelstein [38], in developing IPCW semi-parametric regression and
Kaplan-Meier estimators, additionally proposed IPCW tests for survival data as score tests
derived from the estimation of the regression coefficients.
The nonparametric regression estimators for waiting times from a multi-stage model
we propose are analogues of the nonparametric regression estimators for survival data
introduced by Aalen [2, 3, 4]. This model has received considerably less attention than
other regression models for survival data, such as the semi-parametric Cox model [9], fully
parametric regression models, and the accelerated failure time (AFT) model. There are
notable reasons for this lack of attention. Aalen's model directly models the hazard
function, rather than an exponential or logarithmic transform of the hazard function as
with the Cox and AFT models. While this makes Aalen's model conceptually simpler to
define, negative estimates of the hazard are possible. Regression matrices of less than full
column rank can cause erratic behavior of hazard estimates provided by Aalen's model,
particularly at later times of observation when the risk set is small. Nevertheless, Aalen's
non parametric linear model provides unique flexibility in modeling the hazard as it not only
permits time-varying covariates (like the Cox and AFT models) but defines its regression
coefficients as functions of time rather than as static values, (i.e.) the regression coefficients
are time-varying as well. This unique flexibility uncovers an additional drawback in that
Aalen's model estimates integrated regression coefficients which can be difficult to
interpret. However, kernel smoothing techniques can be used to generate smoothed
estimates of the regression coefficient functions and ad hoc solutions to the other difficulties
- setting a lower bound of zero for model-generated hazard estimates and skipping failure
times for which the regression matrix is rank deficient [20] - generally perform well and
mitigate these problems to some degree. Other than the development of tests of covariate
effects from Aalen's model [17, 30], limited further research into this model has been
conducted. No direct extensions of Aalen's model to multi-stage data have been proposed.
We detail our IPCW test statistics and non parametric regression estimators for
waiting times from multi-stage models in the following chapters, which are organized as
follows. In Chapter II, we develop our notation, review the principle of IPCW and the
waiting time cumulative hazard and survival function estimators of Satten and Datta [44],
define a model for estimating the censoring hazard which is necessary for the practical use
of our proposed statistics, and establish technical results for use in subsequent chapters. In
Chapter III, we introduce test statistics for the comparison of waiting time distributions
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among K-groups. In Chapter IV, we review Aalen's nonparametric linear model for
survival data and develop nonparametric regression estimators for waiting times. Both
Chapters III and IV contain the results of simulation studies exploring the asymptotic
properties of our test statistics and regression estimators as well as the analysis of real data
sets demonstrating their use. The dissertation concludes with a discussion of our results
and suggestions for further avenues of research in Chapter V.
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CHAPTER II
NOTATION AND PRELIMINARIES
In this chapter we introduce notation for multi-stage models and review the
estimators of Satten and Datta [44J for the cumulative hazard and survival function for
waiting times in a multi-stage model. In so doing, we review the principle of weighting the
basic counting processes by the inverse probability of censoring, first introduced by Robins
and Rotnitsky [39, 40]. The purpose of this review is to provide motivation for our
proposed test statistics and nonparametric regression estimators for waiting times, and to
establish technical results upon which results later in the text will be based. We note that
some of the proofs in this chapter follow directly from corresponding proofs previously laid
out for survival data [12, 41, 43], but have yet to be formally established for waiting times
in a multi-stage model. Much like the cumulative hazard and survival function estimators,
the test statistics and regression estimators we propose are simple analogues of statistics
commonly used for survival data, with basic counting processes for uncensored data
replaced by their IPCW equivalents. The discussion below largely follows that of Datta
and Satten [11], Satten, Datta, and Robins [42,43]' and Satten and Datta [44]. Specifically,
we restrict our attention to continuous waiting time distributions and acyclic network
structures, (i.e.) networks with no cycles among subsets of the stages. As discussed by
Satten and Datta [44], a cyclic network can be exploded into an acyclic network by
considering the unique times of entry into a given stage, (e.g.) the first, second, third, etc.
entries into a given stage of a cyclic network can be reconstructed as unique stages in the
model. The authors further note that an exploded stage of an acyclically restructured
network subsequently can be pooled to generate hazard and survival function estimates for
"general" stage exit (as opposed to order-specific estimates), so there is no loss of generality.
We briefly note that the notation and preliminary results outlined in this chapter are
in the context of a single sample. This notation will be directly applicable for the
nonparametric regression coefficient estimators proposed in Chapter IV. Chapter III will
deal with hypothesis testing in the K -sample setting, and will necessarily require extended
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notation that will be discussed in that chapter.
Notation
Since we will consider potentially right-censored data from multi-stage models, it
will be necessary in defining our notation to delineate "true" quantities from their censored
counterparts, (i.e.) to differentiate what actually occurs from what is observed by the
experimenter/analyst. In general, we will denote true quantities and functions thereof with
an asterisk (*) and their observed (censored) equivalents will not be annotated.
Let i (1 :::; i :::; n) index individuals and j (1 :::; j :::; J) index the stages in the model.
Let Iij denote the time individual i enters stage j, and let Utj denote the corresponding
exit time. Note that Iij =

00

if stage j is never entered and UiJ

= 00

if stage j is never

entered or never exited, for example, if stage j is absorbing. Define

Ii* = maxj{Iij I Tij < oo} as the time ofthe last transition for individual i. Let
X ij = I[Iij <

00]

be the indicator of individual i ever entering stage j. The values

Tij, UiJ ' Ii*, and X ij can go unobserved due to right censoring. Let Gi denote the censoring
time for individual i. Define lij = I[Gi

~

Iij] to be the indicator of individual i having

been observed to enter stage j, and 6ij = I[Gi

~

Uij] the indicator of individual i having

been observed to leave stage j. Let Ii = min(T;*, Gi ) be the time of the final observed
transition. Define Tij

=

min(Iij, Gi ) if the data at time t do not imply that X ij

otherwise. Note that

Ti j = 00 if, for example,

=

0 and

00

an individual proceeds down a path in the

network from which stage j is unreachable. Let Uij = min (UiJ , Gi ) if j is not absorbing and
the data at time t do not imply that X ij = 0 and

00

otherwise. For the moment, we assume

that the observed data consist of i.i.d. replicates of {Ii j , Uij' lij, 6ij, 1 :::; j :::; J}.
In addition to the entry and exit times and indicators, we observe a set of possibly
time-varying covariates that may impact both the censoring and transition hazards.
Denote the p-vector of these "external" covariates for individual i by
of these values up to and including time t by X~(t). Let F t

Xi (t),

and the history

= {Tij I T;j :::; t}

denote the

history of transitions up to and including time t. Define the vector of "internal" covariates
as X;(t), which are functions only of F t , and denote the history of the these covariates as

X~(t). The collection of internal and external covariates for individual i is denoted by Xi(t)
and its corresponding history as Xi(t).
In the present chapter, we will review the Satten and Datta [44] estimators of the
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waiting time cumulative hazard and survival functions, for which we provide definitions.

P[Ui} - T;j > tlXij = 1] be the survival function for stage j waiting times and
let Aj(t) = Jd ,xj(s)ds be the corresponding cumulative hazard function, where
Let Sj(t)

=

,xj(t)dt

P[UiJ - T;j

=

E

[t, t + dt] lUi} - T;j 2 t] denotes the hazard rate function, the

conditional probability of stage j exit over an infinitesimal interval given that stage j exit
has not occurred prior to t units of time after stage entry.

A Model for the Censoring Hazard
The principle behind estimation by IPCW for survival data introduced by Robins
and Rotnitsky [39, 40] is fairly simple. Many traditional estimators for survival data are
functions of two counting processes - the event process, which counts the number of events
(i.e. deaths or failures) that occur, and the at-risk process, which counts the number of
individuals under consideration that remain at risk of the event. The IPCW estimator for a
given population quantity, such as the survival function, is achieved by replacing the
counting processes composing a traditional estimator for uncensored data with weighted
equivalents, where the weights are defined by some estimate of the inverse probability of
censoring. As will be seen, the IPCW estimators have useful statistical properties but
remain applicable when independent censoring cannot be assumed.
In order to formally define IPCW estimators, we must develop a conceptual model
for the censoring hazard. Following Robins and Rotnitsky [39, 40] and Satten, Datta, and
Robins [42, 43], we assume a censoring mechanism in our multi-stage model in which
knowledge of future transition times does not affect the censoring hazard. Specifically,
letting ,xc (t

I .) denote the censoring hazard,

we assume that

where F t is as defined previously. Note that this assumption indicates that the censoring
hazard, as a function of the history of the external covariates (X~ (t-)) and the history of
transitions (Ft ), is impacted only by the history of transition times up to just before time t,

(Ft -). We further assume that the set of internal covariates, X;(t), which are functions
only of F t , are chosen such that
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Specifically, we are asserting that the history of the internal covariates (X~ (t- )) fully
accounts for any impact that the history of transition times (Ft -) may have on the
censoring hazard. In other words, any information contained in F t - not contained in

X~(t-) does not impact the censoring hazard. Define the cumulative hazard of censoring in
the usual fashion, as N(t I Xi(t))

=

J~ ).C(s I Xi(S-) )ds and the product integral of the

censoring hazard as Ki (t) = TIs:St [1 - dN (s I Xi (s) )]. In what follows, we will typically

I

write ).Ht) to denote ).C(t Xi(t-)). A functional form for ).Ht) will be developed in the
following section. For now, it is sufficient to stipulate that the censoring hazard at time t is
defined as a function of the covariates (internal and external) up to just before t.

Marginal Estimators of the Waiting Time Distribution
For uncensored data, in which the stage entry and exit times are fully observed, one
could estimate Sj(t) and Aj(t) using the Nelson-Aalen and Kaplan-Meier estimators for
waiting times. To this end, define the uncensored data counting process for exits from stage
j as N;(t)

=

~*(t) = L~=l

L~=l

I[UiJ - ~j ~ t, Xij = 1], and define the corresponding at risk process as
I[UiJ - ~j 2: t, Xij = 1]. The uncensored data estimators for the stage j

waiting time cumulative hazard and survival functions are then

rt

*
dN;(s)
Aj(t) = io ~*(s)'

Sj*)
(t =

II (1 -

s:St

dNJ(S))
y* () ,
J

(2.1)

S

where IT denotes the product integral. The estimators in (2.1) cannot be used for censored
multi-stage data, but establish a useful foundation upon which to base IPCW estimators.
Estimators for right-censored data could be derived by replacing in (2.1) the uncensored
data counting processes with their censored data equivalents:

Nj(t) = L~l I[Uij - ~j ~ t, Oij = 1] and Yj(t) = L~=l I[Uij - Tij 2: t, "iij = 1]. However, as
noted in Chapter I, the applicability of such estimators generally requires the assumption
of independent censoring and the semi-Markov property.
As noted in the previous section, the IPCW estimators of the cumulative hazard and
survival function for waiting times are derived by replacing the traditional counting
processes (censored or uncensored) with their weighted equivalents. The Ki(t) defined in
the previous section serve as our probabilities of censoring, and thus our inverse probability
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of censoring weights. Define the weighted event and at-risk counting processes as follows:

Note that we have weighted the censored data counting processes N j (t) and Yj (t), since
weighting the uncensored data counting processes would still require uncensored data and
be of little practical use. However, the justification for the use of N j and Y j lies in a
correspondence with the uncensored data counting processes Nj and

~.

defined by the

following theorem.
Theorem 11.1 Let i be such that E[Ki- 2 (i)] <

00

for 1 :S i :S n. Then

E[Nj(t)]

E[N;(t)],

E[Yj(t)]

E[~·(t)].

Before proving Theorem 11.1, we prove a useful technical lemma, that will be used in
proofs of future theorems as well. The proof of the lemma involves an application of the
Duhamel equation (cf. Andersen, et al [6], Thm. 11.6.2), and follows the arguments laid out
in a similar proof by Satten, Datta, and Robins [43] for survival data (as does the proof of
Theorem ILl). Before proceeding, define 1VNt) = J[Ci :S t, Ci :S

~.]

to be the counting

process of censoring events and MHt) = NiC(t) - I[Ti 2: t]Af(t) to be the associated
martingale, where Af(t) is the cumulative hazard of censoring as previously defined. Note
that in defining the censoring event counting process and martingale we have used t to
denote time, as with the counting processes associated with stage exit. Despite this, it is
important to distinguish that the stage exit process evolves conditional upon stage entry
(i.e. after time

~j

for individual i) whereas the censoring process evolves in so-called

"calendar time", after observation begins in the multi-stage system. In other words, the t
in Nj(t) refers to time t after entry into stage j, whereas the t in NiC(t) refers to time t after
observation of the multi-stage system begins (at time 0). We will carefully distinguish these
two time scales (calendar time and time after stage entry) as needed when we layout our
results. We then have the following:
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Lemma 11.2 For t

~

Tt,
I[Ci 2:: t] = 1 _ r~ I[Ci 2:: s] dMns).
Ki(t-)
Jo Ki(S)

Proof. Note that I[Ci 2:: t] = TIs<t [1

+ dXi(s)],

where Xi(S)

=

-I [a;

we have Xi (s) = - I [Ci ~ s, Ci ~ Tt] = - Nic (s ). On the set {Ci 2::

~

s]. For s < t

~

Tt,

I:*}, we have

Ki(t-) = TIs<t[l - dX;(s)], where X;(s) = I [Ii 2:: s] AHs). By the Duhamel equation, we
get

I[Ci 2:: t] =
rt~ I[Ci 2:: s] (dX() dX'())
Ki(t-)
1+ Jo Ki(S)
,s +
,s .
Note that Xi(S)

+ X;(s) =

-NiC(s)

+ I[T; 2::

s]AHs) = -MiC(s). Hence,

We make a brief note that this proof also carries through if we replace Ki (t-) by

•

some estimator K i ( t- ), with the modification that the right hand side integral is taken
with respect to dMiC(s), where MiC(s) = Nns) - I[Ti 2:: s]Ai(s) and Ai(t) is the estimator of

Af(t) generating Ki(t) via the product integral. The quantity MiC(s) also does not define a
martingale, but will be useful in later results. Note also that the proof of Lemma II.2 made
no assumption of the relationship between the censoring times Ci and the transition times
Tij , (i.e.) neither the assumption of independent censoring nor the semi-Markov property

were required. Lemma II.2 will be used repeatedly in several later proofs.
Proof of Theorem II. 1.

Lemma II.2, i.e. Ui}

~

To prove the first equality, note that Uij satisfies the conditions of

I:*.

Hence,

Multiplying both sides by I[Ui}

-

I:j

~

t] produces

I[Ui} - I:j ~ t, Ci 2:: Ui}] = I[U*. _ T*. < t] _ rU;j- f[Ui} - I:j :; t] dMC( )
Ki(Uij-)
'J
'J Jo
Ki(S)
, S,
where the I [Ci 2:: s] term in the integrand on the right hand side can be removed since the
martingale Mns) vanishes for Ci < s. On the left hand side, the indicator function in the
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numerator is equivalent to f[Uij - T;j S; t, Ci 2: Ui]]. Further, on the set {Ci 2: Ui]}' we
have that Ki(Ui]-) = Ki(Uij -) and trivially on the right hand side, f[Ui] - T;j S; t]

=

I[Ui] - T;j S; t, Xij = 1:. Hence, we have
N .(t)
'J

=

N*.(t) _ rU;j- I[Ui] - T;j S; t] dM
'J
io
Ki (s)
,

C(

)

S •

We note that f[Ui] - T;j S; tJlKi(s) is Fs-predictable, and hence the integral on the right
hand side is a zero-mean martingale (since MiC(s) is). The first equality follows by taking
the expectation of both sides, under the stated moment condition on Ki(S).
The proof of the second equality follows similarly, by noting that on the set

{Ui} - T;j 2: t}, T;j

+ t satisfies for

the conditions of Lemma I.1 so that

(For times after Ui}' both r:;(t) and Yij(t) are zero.) Multiplying both sides by

f[Ui] - T;j 2: t] produces
f[U*''J - T*'J > ,t. Ci -> T*'J
Ki(T;j + t-)

+ t] = f[U*'.

_ T* > t] _

'J

'J -

1

T ;j+t-

0

f[U*'.'J - T*·'J >
t] dM C ( )
Ki(S)
, S.

The numerator on the left hand side is equivalent to I[Uij - T;j 2: t, Ci 2: T;j], and on the
set {Ci 2: T;j}, we have that Ki(Tij

f[Ui} - T;j 2: t]

=

+ t-) =

Ki(T;j

+ t-)

and we trivially have that

f[Ui]- T;j 2: t,Xij = 1]. Hence, we have that
Y .. (t) = Y*'(t) 'J

'J

TtJ+t

1
0

flU'!'. - T*· >
'J
'J Ki (s )

tJ dM~()
,

S .

Again, the result follows by noting that f[Ui] - T;j 2: t]/Ki (s) is Fs-predictable, the right
hand side integral is a zero mean martingale, and taking expectations.

•
The large sample equivalence of the uncensored data and IPCW counting processes
indicates that inference based on the IPCW processes will be asymptotically equivalent to
inference based on the uncensored data processes, a clearly desirable property. In essence,
N j and Y j "estimate" the uncensored data counting processes N; and

~*.,

which are

unobservable when right-censoring is present. However, the reweighted counting processes
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N j and Y j are of little practical use since they are based upon the quantity Ki(t) which is
typically unknown. The application of the IPCW counting processes requires an estimator
for Ki(t). In introducing IPCW, Robins and Rotnitsky [39, 40] used the well-known Cox
proportional hazards model [9]. Datta and Satten [12] suggested the use of Aalen's linear
model [2, 3, 4] for the added flexibility of time-varying model coefficients, and we adopt its
usage here. We briefly note that in suggesting the use of Aalen's linear model, Datta and
Satten argue that the potential negative side effects of its use (regression matrices with less
than full column rank and negative estimates of the hazard function) do not impact the
estimation of the cumulative hazard or survival function for stage waiting times [12,43,44].
We now define Aalen's linear model for the censoring hazard in our current
framework: Af(t)

= ,88(t) + l.:~=l ,8;,,(t)Xim(t) , where the ,8;,,(t) are the coefficient functions

and m indexes both internal and external covariates. Note, in particular, that both the
regression coefficients ,8;" (t) and covariates X im (t) are time-varying functions rather than
static values, the source of the unique flexibility of Aalen's model. Define the integrated
regression coefficients B;,,(t)

=

J~ ,8;" (s)ds, 0 :::; m :::; p. Aalen's linear model estimates the

functions BC(t) = (B8(t), .. . ,B~(t)) by
n

BC(t) =

L J(T; :::; t)(1 -

bi)A -l(T;)Xi(Ti ),

i=l
where bi

=

J[~*

< Gi ] and A(t) =

l.:~=l J(Ti

2 t)Xi(t)X[(t). Note that we have defined the

estimator BC(t) in terms of a specific generalized inverse for A(t), namely A -l(t)Xi(i)
which arises from the least squares principle, and that any generalized inverse of A(t) will
suffice. We are now able to estimate the censoring hazard and our inverse probability of
censoring weights, Ai(t)

= J~ X[(s)dBC(s)

and Ki(t)

We now define the counting processes Nj(t)

= TIS S t(1- dAi(s)).

= J[Uij - T;j :::; t, bij = Il/Kij(t) and

Yj(t) = J[Uij - T;j 2 t, "tij = 1l/ Kij(t), which are completely functions of the observable
data. The Satten and Datta [44] estimators for the cumulative hazard and survival
functions for stage j waiting times are then

(2.2)

As indicated above, the IPCW estimators are simple analogues of the uncensored data
estimators in (2.1), with the uncensored data counting processes replaced by their IPCW
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equivalents. These estimators, as functions of the IPCW counting processes, are calculable
of the observable data. The consistency of these estimators for Aj(t) and Sj(t) is
established in the following theorem.
Theorem 11.3 Let

T

be such that

T

1 ::; i ::; n and assume that for all T

> T; for all i. Let t be such that E[Ki- 2 (t)J <
< T,

n- l

SUPtST

L?=l

IKi(t) - Ki(t)1 ~

o.

CXl

for

Then

Proofs of this theorem (and similar versions for survival data) can be found in the
literature [11, 42, 43], and are not repeated here. We do note that the proofs are invariant
to the method of estimation of Ki(t) and when Aalen's linear model is used, invariant to
the type of gellemli:t;eu invertie of the matrix A(t) selected. These choices do playa role in

defining the asymptotic distribution of Aj(t), as will be seen below.
The proof of the consistency of Aj (t) and

5j (t)

rests on a martingale representation

for Aj(t) developed by Satten and Datta [44], which we establish in the following lemma.
Lemma II.4 Let J;(t) = I[Yj*(t) >

OJ.

For Aj(t) defined in (2.2),

rt J;(s) dM*(s) +

10

10

Yj*(s)

00

(;(s, t)

J

[1 - X(s)A -1(S)XT(s)] dMC(s) + op(n- I/

2

),

(2.3)

where
_
[ I[TI > sJ ·Xf(s) )
X(s) =
:
,

Ml(s) )
MC(s) =

:
[

I[Tn > sJ . XJ(s)

,

M~(s)

<Pj ( I[s - t < T;jJ
I[s - t < T;jJ
nKi(S) Sj (t /\ (Utj - T;j)) - Sj ((0 V (s - Tij)) /\ (Uij - T;j))
I [s < U*·
tJ)
'J' W·'J - T*'J <
-

and <Pj = P[Xij =

1J.
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(2.4)

The proof of Lemma Il.4 is long and fairly technical, and we defer it to the Appendix. We
note that this expression corrects errors in the limits of integration in the second integral of
(2.3) and in the definition of (ij(5; t) in (2.4) defined by Satten and Datta [44].
The martingale representation (2.3) provides an avenue for deriving the asymptotic
distribution of Xj(t) and Sj(t) via the martingale central limit theorem (cf. Andersen, et al
[6], Thm. 11.5.1). As our focus is on K-sample test statistics and nonparametric regression
coefficient estimators, we do not further explore the asymptotic properties of Xj(t) and

Sj(t). We do, however, remark that (II.4) is the sum of two martingales which are
orthogonal with respect to the filtration generated by the observed data,

O'(Ft, Xi, 1 ::; i ::; n):
1. a martingale derived as the stochastic integral of a predictable process with respect to
the waiting time martingale

~

M;(t),

2. a martingale derived as the stochastic integral of a predictable process with respect to
the vector-valued censoring hazard martingale

~

MC(t).

The orthogonality of these martingales is important ~ the asymptotic properties of

Xj

consequently can be derived from those of the two component martingales with no
consideration of their covariance. This martingale representation will be revisited in
defining the asymptotic properties of our K -sample test statistics and non parametric
regression estimators for waiting times in the following chapters.
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CHAPTER III
NONPARAMETRIC K-GROUP HYPOTHESIS TESTING
We now turn our attention to the comparison of stage j waiting time distributions
among K groups of individuals. The null hypothesis is simply stated, Ho : A lj = ... = AKj ,
where Ahj denotes the stage j cumulative hazard function for group h. We note that Ho is
equivalent to hypothesizing the equivalence of the K waiting time distributions, given that
we have assumed continuous waiting time distributions and the functional equivalence
Ahj(t)

= -log Shj(t). Many well-known test statistics for survival data, including the

log-rank test and the more general class of Fleming-Harrington [16] tests, can be derived as
the weighted accumulation of differences between estimates of the K group-specific
cumulative hazards and the overall cumulative hazard [6]. We develop our waiting time
test statistics analogously. As with the Satten and Datta [44] cumulative hazard and
survival function estimators for waiting times described in the previous chapter, we proceed
by introducing test statistics for uncensored waiting time data (adapted from test statistics
for survival data) and then replacing the uncensored data counting process composing
these statistics with their IPCW counterparts.
We begin the chapter with a brief exposition of the extension of our notation and
the affirmation of the results from the previous chapter to the K -sample setting. We then
introduce test statistics for uncensored waiting time data as described by Andersen, et al [6]
for survival data. We then derive our IPCW test statistics and establish their asymptotic
normality and then proceed to an exploration of their empirical size and power via
simulation studies for waiting time data. In the validation portion of our simulation study,
we assess the properties of our test while noting the inadequacy of traditional survival data
test statistics under violations of the semi-Markov property. In the comparison portion of
our simulation study, we compare the power of our test with a Mann-Whitney type test for
waiting times [15] for proportional hazards alternatives, for which the log rank test for
survival data is most powerful. We conclude the chapter by illustrating the use of our test
statistics with an analysis of a data set of 154 burn patients [23].
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Expansion of Notation
In general, we will prefix the subscript h (1 ::; h ::; K) to subscripts i, j, and ij to
denote group membership. The index i for individuals consequently ranges from 1 to nh,
where nh denotes the number of individuals in group h, and 2:h nh

=

n. The stage index j

is unaffected. We summarize the notational expansion in the following list.
• The uncensored data quantities Thij , Uhij , Thi , and X hi and the censoring times Chi
are now indexed for subject i in group h, and are otherwise defined identically as
before.
• The censored data quantities Thij , Uhij , Thi , 'Yhij, and bhij and the covariate vectors

X hi and histories X hi are now indexed for subject i in group h, and are otherwise
defined identically as before. The history of transition times F t is pooled over the K
groups and remains unchanged.
• All counting processes - Nhj(t), Nhj(t), N hj, N hj , Yhj(t) , Yhj(t) , Y hj, and Yhj - are now
indexed for group h and are otherwise defined identically as before. These counting
processes pooled over the K groups will be denoted as

Nj( t)

=

2:h N hj (t), N.j(t)

=

2:h Nhj(t) , etc.

• The cumulative hazard and survival functions Ahj(t) and Shj(t) are now indexed for
group h, as are their uncensored data estimators A;'j(t) and Shit) and IPCW
estimators Ahj(t) and Shj(t). The estimators are defined in terms of the group
specific counting processes, but are otherwise defined identically as before. The
corresponding quantities pooled over the K groups are denoted A-j(t), B.j(t), Nit),

B.j(t), A-j(t), and

5. j(t),

with the estimators defined in terms of the pooled counting

processes, (e.g.) A;'j(t) = J~ dNhj(s)/Yhj(s).
• The censoring hazard Ahi(t) and corresponding product integral Khi(t) are now
indexed for subject i in group h, and are otherwise defined identically as before, as
are the counting processes for censoring events

• Aalen's linear model is defined as Ahi(t) = J3o(t)

N~i(t)

and the associated martingale

+ 2:~=1 J3~(t)Xhim(t)

for individual i

in group h. The integrated coefficient vector BC(t) is estimated by

:8 (t)
C

=

2:-;;=1 2:~~1 J(Thi ::; t)(l - bhi)A -1 (Thi)Xhi(nd.
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The cumulative hazard of

censoring and product integral estimators are AhJt) = J~ XIi(s)dBC(s) and

Khi(t) = f1s$t(1- dAhi(s)), analogous to the I-sample setting with the added
subscripts h. Note that BC(t) is pooled over the K groups; group-specific estimates
can be obtained by explicitly including a K - 1 vector of covariates indicating group
status .
• Group-specific versions of Theorem 11.1, Lemma 11.2, Theorem 11.3, and Lemma II.4
hold with proofs identical to the one-sample setting. In Lemma 11.4, the matrix X(s)
and the vector MC(s) are ordered lexicographically, as is the modified vector (f(s, t),
as follows:

(

I[Tll > S]Xfl(S)

(

\

I[TIllI > S]XfllI (s)

X(s)

\

{

\

({L(s, t)
([;Jj(s, t)

MInI (s)

, MC(s)

=

Mrl (s)

, (f(s,t) =

=

I[TKI > S]Xkl(S)

M.b(s)

(§lj(S, t)

I[TKllK > S]XkllK(S)

M'knK(s)

(§nKj(s, t)

where the functions (!Sj(s, t) are modifications of the functions (ij(S, t) as defined in (2.4):
x
1
'1!hj
II 1[:-; - t <--- m*
-1 hijJ
nhKhi(S) \Shj(tl\(Uhij-Thij))

t

Shj ((0 V
where iphj

= P[Xhij = 1]

l[s - < Thij ]
1[s < Uhij , Uhij - Thij :::;
(s - Thij )) 1\ (Uhij - Thij )) Shj(Uhij - Thij )

t])
,

denotes the probability of an individual in group h ever reaching

stage j. Note that the superscript K in (f(s,t) is not an index, rather meant to denote the
K-sample version the function (j(s, t) defined in (2.4). Further, we extend the martingale
representation of Aj(t) in (2.3) to the K-sample setting as follows:

(3.1)
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We preserve our notational conventions with respect to the quantities and functions of
interest. Uncensored data quantities (entry and exit times) are marked with asterisks and
censored data quantities are not marked. Censored data functions (counting processes,
covariate functions) are marked with asterisks, censored data functions are unmarked, and
weighted functions (counting processes, estimators) are hatted. With this K -sample
notation and group-specific results from Chapter II, we now proceed to developing our
waiting time test statistics.
Waiting Time Test Statistics for K Groups
In order to develop our test statistics as weighted accumulations of differences
between the group-specific and pooled cumulative hazard estimates, we define the
stochastic weight processes Whj(t), 1 :S h :S K. As in Andersen, et al [6], we constrain
attention to weight processes of the form Whj(t) = Wj*(t)Yh'j(t), where Wj*(t) is a
non-negative, locally bounded, predictable function depending only on the pair

(Nj (t),

Y; (t)).

This general formulation covers many test statistics for survival data,

including the log-rank and Fleming-Harrington class of tests, although more general weight
processes are permitted.
To test Ho : Alj

= ... =

AKj for uncensored waiting times, we define the test

statistics
(3.2)
The integral in (3.2) accumulates the differences between the estimated group-specific
cumulative hazard, Ahj(t)

A":j (t) = J~ dNj (s ) /

= J~dNhj(s)/Yh'j(s),

and the pooled cumulative hazard,

Y; (s), weighted by Wj* (s )Yh'j (s ). The statistics Z;'j (t) present a

reasonable test of Ho at face - large deviations of group-specific cumulative hazards from
the pooled cumulative hazards produce large values of Z;'j(t) and provide evidence against

Ho. The weight process provides some flexibility in tailoring Zhit) to a given data set or a
priori suspicion about the nature of the difference in hazard between groups. For example,
weight processes can be defined that more heavily weight early differences in the
cumulative hazard functions.
Plugging in the Nelson-Aalen estimators Ahj and A":j into (3.2) produces
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Under the null hypothesis, A'h,j

=

Aj, so we can add zero in the form of dAj(s) - dA'h,j(s)

to get

where M'; = 2:\ M hj and b.. h1 denotes the Kronecker delta. Based on this martingale
representation, the predictable covariation process of the Zh,j(t) is

The expectation of (3.3) provides the covariance of the Z"j(t) and Zk/t), which can be
estimated by

(3.4)

Tests of Ho can be based upon the quadratic form Z;(t)T'Ej-(t)Z;(t), where the vector

Z;(t) = (Z~j(t), ... , ZKj(t)), 'E;(t) is the matrix with (h, k)ih element defined by (3.4), and
'E;- (t) is a generalized inverse of 'E; (t). Under mild conditions (see Andersen, et al [6]),

E;(t) has rank K - 1 and an alternative but equivalent quadratic form can be constructed
as ZOj(t)T'Eojl(t)ZOj(t), where ZOj(t) is Z;(t) with a single element removed and 'EOj(t) is

'E;(t) with the corresponding row and column removed. Under mild regularity conditions,
Z;(t) converges weakly to a normal limit (d. Andersen, et al [6], Thm. V.2.1), so that
either of the above quadratic forms follows the X2 distribution, providing critical values for
the test statistic.
Clearly, Z;(t) is of little use for right-censored multi-stage data being based on
uncensored data quantities. Further, test statistics based on unweighted, censored data
counting processes would require independent censoring and the semi-Markov property to
be valid. Hence, we propose testing Ho with IPCW versions of (3.2) where, as with the
Satten and Datta [44] estimators described in Chapter II, we replace uncensored data
quantities with their IPCW counterparts. We can then define IPCW K -sample test
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statistics for waiting times in a multi-stage model as,

(3.5)
where Ahj(t) and A.j(t) are as defined in (2.2) in Chapter II. Note that we have redefined
the weight process Wj(S)Yhj(S) in terms of the IPCW counting process Yhj(s), where Wj(s)
remains a non-negative, locally bounded, predictable function but now depends on the
IPCW pair (Nj(t), Yj(t)). We will generally focus on the log-rank weight process

Wj(s) = ~(s) = I[~(s) > 0]. In particular, we will use this weight process in our
simulation study of Zhj(t). The formulation of Zhj(t) in (3.5) can alternatively be
expressed as

We note that this formulation highlights that Zhj(t) also accumulates differences between
what is observed for group h and what is expected. Temporarily ignoring the weights

Wj(t), the first term merely counts the group h exits from stage j, while the second term
counts exits from stage j for all groups weighted by the IPCW-estimated proportion of
subjects in group h - Yhj(s)/Yj(s).
Asymptotic Properties of the Test Statistic
The use of Z hj (t) in testing requires derivation of the asymptotic distri bu tion of the
vector Zj(t) = (Zlj(t), ... , ZKj(t). We begin by deriving a martingale representation for
the Zhj(t) which follows from the representation for Ahj(t) in (3.1). Under the null
hypothesis, note that A hj

=

A-j, and hence for 1 ::::; h ::::; K,

Substituting in the martingale representations for Ahj(t) - Ahj(t) and A.j(t) - A.j(t) gives

rt -

rt -

~
~
Jhj(s)
*
~
1.;(s) *
Zhj(t) = io Wj(S)Yhj(S)Yhj(S) c1Mhj (s) - io Wj(s)Yhj(s)Yj(s) c1M-j(s)-

, foOO{fot Wj (U)Yhj (u)(f (s, du)T} [I - X(s)A -l(S)XT(s)] dMC(s) +
foOO{fot Wj(u)Yhj(u)(j(s, du)T} [I - X(s)A -l(S)XT(S)] dMC(s) + op(n- 1/ 2 ).
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(3.6)

Note that the first and third terms of (3.6) are the martingale expression for Ahj(t) and the
second and fourth terms for Aj(t). By exploiting the asymptotic equivalence of Yj*(t) and

Yj(t) (noted in the proof of Lemma 11.4) and noting that M.; = Lh M hj , we can further
simplify (3.6):

(3.7)

where

".,f (s, t) is defined by

As with the expansion of Ahj(t), the martingale representation for Zhj(t) is the sum
of two martingales, one associated with the stage j exit counting process (Mhj(t)) and one
with the counting process of censoring events (MC(t)). Further, the martingales are
orthogonal with respect to the filtration of the observed data. Hence, the asymptotic
properties of the K-vector of test statistics Zj(t) can be derived from the asymptotic
properties of the two component martingales via the martingale central limit theorem, and
covariance considerations can be ignored. It is also noteworthy that the the first term of
(3.7) directly corresponds to the uncensored data K-group test statistic in (3.2), for which
conditions required for asymptotic normality are well-defined [6].
An immediate consequence of the orthogonality of the two martingales in (3.7) is
that the predictable covariation process (cf. Eq. 2.3.7, [6]) of two components of Zj(t), say

Zhj(t) and Zkj(t), can be defined as the sum of the predictable covariation processes of the
component terms of (3.7). Specifically,
{t - 2
*
(
Yki(S))
10 Wj (S)Yhj(S) ~hk - Yj(s) Aj(s)ds +

10

00

".,f(S,t)T [1-X(s)A-l(S)XT(S)]

X

1,),(s) x

[I - X(s)A -l(S)XT(s)] ".,f (s, t)ds + op(n-

1 2
/ ),

(3.8)

where 1>.(s) is the matrix diag{I[Tn ~ s]Afl (s), . .. ,I[TKnK ~ S]AKnK(s)}. The asymptotic
covariance of Zhj(t) and Zkj(t) is then the in-probability limit of (3.8). Let (T~k(t) denote
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the in-probability limit of the predictable covariation process (3.8) and define the matrix

:Ej(t)

=

{O"hk(t)}. Other than establishing a limiting variance for Zj(t), this expression is of

little practical use as it based upon the uncensored data counting processes Y,;'j(t) and

Y;(t), the population quantities AAs) and Ahi(S), and ([(s, t), which is constructed from
the uncensored entry and exit times Thij and Uhij and the population quantities Shj(t) and
<'P hj .

We can estimate (3.8) by the optional covariation process (cf. Eq. 2.3.8, [6]) of Zhj(t)

and Zkj(t) as follows:

lot Wf(s) ~j(s) (jj.hk _ ~j(S)) dNj(s) +
o

10

Yj(s)

00

i]f (s, t)T

rl - X(s)A

-1

Yj(s)

[I - X(s)A -l(S)XT(s)] x IN(S) x
(s )XT (s) 1i]f (s, t),
~

L

(3.9)

-

where i]J(s,t) = JJWj(u)Yhj(u) (([(s,du) - (j(s,du)), IN(S) denotes the diagonal matrix

diag{dNf1(S), ... , dNKnK(S)}, and the components of ([(s, t) are

(3.10)

Note also that

(/5/s, t) =

:'4.,:: (hij(S, t) to complete the definition of the optional variation

process (3.9). In (3.10), Shj(t) represents the Satten-Datta estimator and the estimator 1>hj
can be calculated using the method of Datta and Satten [11]. Denote the optional variation
process in (3.9) by iThk(t) and define the matrix :Ej(t)

= {iThk(t)}.

Given the variance expressions (3.8) and (3.9) and that Zj(t) is a martingale, being
the sum of two orthogonal martingales, we can assert the asymptotic normality of Zj(t) by
imposing the conditions of Rebelledo's martingale central limit theorem. We note that the
two assumptions required for a martingale to be asymptotically normal (c.f. Thm. II.5.1,
[6]) are that (1) either its predictable or optional covariation process converges in
probability to a continuous, deterministic, positive semi-definite limit with positive
semi-definite increments in time, and (2) the Lindeberg condition, that its "path" in time
approaches a continuous limit. The following theorem establishes our main result for the
test statistic Zj (t).
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Theorem 111.1 Under Ho : Alj = ... = A Kj and suitable regularity conditions,

Jrizj(t) ~ U(t),
as n

--+ 00

where U (t) = (Ul (t), ... , UK (t)) is a Gaussian martingale with covariance

matrix bj(t) = {O"hk(t)}.
The definition of the regularity conditions stated in theorem and the proof of the
theorem are deferred to the Appendix. As a consequence of this result and similarly to the
uncensored data test statistic, we can establish a K-group test of Ho by calculating the X2
statistic Zj(t)f:j(t)Zj(t), where f:j(t) is a generalized inverse of f:(t). Again, under mild
conditions (see, e.g., [6]), this statistic will have rank K - 1, and tests of Ho can
aiternatively be based upon the chi-square statistic ZOj(t)f:ol(t)ZOj(t), where ZOj(t) is

Zj(t) with a single row removed, f:o(t) is f:(t) with the corresponding row and column
removed, and f:ol(t) is an ordinary inverse of f:o(t). We demonstrate the use of this
chi-square statistic in the following sections.
Simulation Study - Validation
In this section, we present the results of a simple simulation study that examined
the size and power of our proposed test statistic. We compared the size and power of the
log-rank version of Zj(t), for which Wj(t) = 1;(t) = I[Yj(t) > 0], to that of the log-rank
test statistic for survival data adapted to stage j waiting times, defined as the vector

Zj(t) = (Zlj(t) , ... , ZKj(t))T. The components of Zj(t) are defined in terms of the
censored, unweighted counting processes Yhj(t) and Nhj(t) defined in Chapter II as

Zhj(t) = Nh;(t) - J~Yhj(s)/Yj(s)dN.j(s). We considered a three-stage tracking model, in
which individuals entered root stage 0 at time 0 and then progressed through transient
stage 1 on to absorbing stage 2 or were censored, and analyzed stage 1 waiting times. The
power of Zl(t) and Zl(t) were calculated as the observed proportion of 10,000 Monte Carlo
replications in which the null hypothesis of the equality of stage 1 waiting time
distributions was rejected. Rejection was defined as the test statistic ZOj(t)f:ol(t)ZOj(t)
exceeding 95 th percentile of the xi distribution, where ZOj(t) and f:ol(t) were as defined in
the previous section. For computational convenience, bootstrap resampling [14] at 250
loops was used to calculate the standard error of our test statistic, as the covariance
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estimator (3.8) is computationally intensive, requiring in particular the double integration
of the bivariate function

flf (s, t).

We considered per-group sample sizes of 50, 100, and 250

for two designs under which we altered parameters governing the bivariate distribution of
stage 0 and 1 waiting times as follows.
1. Correlated lognormal stage 0 and 1 waiting times. Let (Wo, WI) denote the bivariate

pair of stage 0 and 1 waiting times. We simulated (log(Wo) , 10g(Wd) as a bivariate
normal pair, with mean vector (1,1) in group 1 and (1,11) in group 2, where 11 varied
from 1 to 2.5 to cover the null (11 = 1) and alternative (11 > 1) hypotheses. Marginal
variances were set equal to I, and the correlation between 10g(Wo) and 10g(Wt) was
set equal to p, where p took values -0.5, 0, and 0.5. The bivariate pair was then
exponentiated to produce lognormal waiting times. We crossed the three possible
correlation values between the two groups, for a total of nine variants of this design.
2. Markov chain with gamma-distributed waiting times. We simulated Stage 0 waiting
times from the gamma distribution with shape parameter 2 and scale parameter 1 or
2, different in each group so that one group experienced longer waits (scale = 2) in
stage O. We generated stage 1 waiting times that were positively and negatively
associated with stage 0 waiting times through the equations

(3.11)
where Wo represents the waiting time for stage 0, Fr the gamma distribution function
with group-appropriate shape and scale parameters, U a uniform (0,1) random
variable, and

Pi l the gamma quantile function. In group I, this quantile function

had shape parameter 2 and scale parameter 1. In group 2, the shape parameter for
the quantile function ranged from 2 to 3.5, to cover the null (shape = 2) and
alternative (shape> 2) hypotheses, and the scale parameter was 1. We crossed the
three design parameters - direction of group 1 association (+ / - ), direction of group
2 association (+ / - ), stage 0 gamma scale parameter (lor 2) - to produce 8 variants
of this design. We note that the approximate rank correlations between stage 0 and
stage 1 waiting times under design 2 were

± 0.67, depending on the direction of the

correlation induced by the formulas in (3.11).
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Table 1
Censoring rates for test statistic simulations under the null hypothesis

Design
1

2

Waiting Time Distributions
Stage 0
Stage 1
Correlation
-0.5
10g-N(1, 1) 10g-N(1, 1)
0
0.5
r(2, 1)

+

r(2, 1)

+

r(2, 2)

Censoring Rates (%)
Stage 0 Stage 1 Never
22
39
39
39
28
33
28
39
33
18
18
42
42

13
13
10
14

69
69
48
44

For each design, censoring times were generat.ecl from the Weibull distribution with
shape parameter 2 and scale parameter 5, independent of stage waiting times.
Consequently, to estimate Khi(t) and construct the weighted counting processes Nhj(t) and

Yhj(t), we applied Aalen's linear model with a single time-invariant covariate denoting
group status, for which Khi(t) is the Kaplan-Meier estimator within each group. We
selected independent censoring so that are simulations modeled a problem unique to
multi-stage models, (i.e.) the data generated satisfy the independent censoring assumption
but do not have the semi-Markov property. Table 1 provides the censoring rates for
different combinations of the design parameters for designs 1 and 2. Note that in variants
1-4 of design 2, stage 0 waiting times from group 2 were longer (generated from the r(2, 2)
distribution) than waiting times from group 1 (generated from the r(2, 1) distribution),
and vice versa for variants 5-8.
The empirical size of our test statistic is compared to that of the naive log-rank test
in Table 2. Note that given 10,000 iterations per estimated empirical size, the standard
error for each calculated empirical size was no more than 0.005. For size estimates near the
nominal 5% level, the standard error was approximately 0.002. Our test exhibited size close
to the nominal size of 0.05, while the naive log-rank test exhibited inflated size under all
variants of each design. The departure from the nominal size of 0.05 for the naive log-rank
test was smallest in variants of design 1 in which the correlation between stage 0 and 1
waiting times was equal in the two groups (variants 1, 5, and 9) for N = 100. The
empirical size of the naive log-rank test increased with sample size for all variants of both
designs, and in particular for variants 1, 5, and 9 of design 1, under which the empirical
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Table 2
Empirical size estimates of IPCW test and naive log-rank test at nominal 5% level
DesignVariant

Waiting Time Corr.
Group 1 Group 2

Zl (t)
200
0.048
0.049
0.049

500
0.048
0.052
0.051

N = 100
0.064
0.193
0.449

Zl (t)
200
0.080
0.332
0.717

500
0.106
0.649
0.980

1-1
1-2
1-3

-0.5

-0.5
0.0
0.5

N = 100
0.049
0.052
0.049

1-4
1-5
1-6

0.0

-0.5
0.0
0.5

0.049
0.051
0.050

0.048
0.050
0.051

0.048
0.048
0.052

0.093
0.057
0.145

0.142
0.056
0.224

0.284
0.059
0.490

1-7
1-8
1-9

0.5

-0.5
0.0
0.5

0.050
0.052
0.048

0.049
0.050
0.049

0.050
0.051
0.052

0.312
0.116
0.053

0.574
0.189
0.051

0.932
0.412
0.054

+
+

0.049
0.049
0.049
0.052

0.050
0.051
0.049
0.050

0.050
0.050
0.049
0.049

0.126
0.551
0.663
0.185

0.196
0.849
0.917
0.312

0.428
0.997
0.999
0.644

+
+

0.050
0.052
0.050
0.051

0.050
0.050
0.050
0.050

0.052
0.048
0.048
0.049

0.120
0.658
0.556
0.187

0.202
0.920
0.850
0.318

0.427
0.999
0.996
0.644

2-1
2-2
2-3
2-4
2-5
2-6
2-7
2-8

+
+
+
+

size of Zl(t) was near 0.05 for N

=

100. Further, as the between-group disparity in the

correlation between stage 0 and 1 waiting times increased, the size of Zl(t) further inflated.
Figure 1 provides power curves for our test under design 1 of the simulation study.
We noted that the power of our test statistic increased both with sample size and with the
magnitude of the marginal difference between stage 1 waiting times. We consider variant 5
of design 1 as a reference case, in which waiting times were uncorrelated for both groups.
Variant 3, in which waiting times were positively correlated in group 2 and negatively
correlated in group 1, exhibited reduced power relative to variant 5. This was a reasonable
phenomenon. Under variant 3, longer waits in stage 1 were associated with longer waits in
stage 0 in group 2. Hence, those in group 2 with long waits in stage 1, (i.e.) those
providing evidence against the null hypothesis, were more likely to be censored. Conversely,
longer waits in stage 1 were associated with shorter waits in stage 0, so those in group 1
with long waits in stage 1, (i.e.) those providing evidence for the null hypothesis, were less
likely to be censored. The converse was true for variant 7, which exhibited greater power
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Figure 1. Empirical power of

Zl

for 9 variants of simulation design 1
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than the reference case. Individuals in group 2 with long stage 1 waiting had shorter stage

o waiting times and were consequently less

likely to be censored (more evidence against the

null), while individuals in group 1 with long stage 1 waiting times were more likely to be
censored (less evidence for the null). In general, when correlations between stage 0 and
stage 1 waiting times induced censoring that provided additional evidence against the null,
(i.e.) when observations in support of the alternative were more likely to be fully observed,
the power of

Zl

increased relative to the reference case. When stage 0 and stage 1 waiting

time correlations left observations in support of the null were more likely to be full
observed, power decreased relative to the reference case. Therefore, we concluded that
while our IPCW test statistic maintained appropriate size under variants of design 1, it was
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Figure 2. Empirical power of Zl for 8 variants of simulation design 2
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not completely immune to dependent censoring patterns, as empirical power varied as a
function of the waiting time correlation.
The power of

Zl

under design 2 was more complexly related to the simulation design

parameters (Figure 2), although we again noted that the power of our test increased with
sample size and the marginal difference between stage 1 waiting times between groups. The
dominating factor in determining the power of the test was the direction of the correlation
between stage 0 and stage 1 waiting times in the group with longer stage 0 waiting times.
When stage 0 waiting times were greater in group 2 (variants 1-4), negative correlation
between stage 0 and stage 1 waiting times in group 2 led to higher power (variants 1 and
2). Alternatively, when stage 0 waiting times in group 1 were longer (variants 5-8), positive
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correlation between stage 0 and 1 waiting times in group 1 led to higher power (variants 6
and 8). Further, the power curves for these four variants (1, 2, 6, and 8) were quite similar,
indicating that other design parameters were of lesser importance. Variants 3, 4, 5, and 7,
exhibited reduced power relative to the other four, and had power curves that were similar
(among themselves).
The importance of the stage 0 waiting times in determining power under design 2
was not unexpected. Because censoring evolves in calendar time, longer waits prior to entry
in stage 1 increase the likelihood of censoring prior to entry into or exit from stage 1 and
heavier censoring tends to reduce power. Hence, any design parameter that exerted direct
influence over the censoring rate, such as the stage 0 waiting times, would be expected to
affect the power. The waiting time correlation, therefore, had a greater impact on power
when it was altered for the group experiencing longer stage 0 waiting times. For
simulations in which group 2 exhibited longer stage 0 waits, power was greatest when
group 2 individuals with long stage 1 waits (supporting the alternative hypothesis) were
least likely to be censored. This occurred when long stage 1 waits were associated with
short stage 0 waits, (i.e.) when there were negative correlations as in variants 1 and 2. The
correlation between waiting times in group 1 did not dramatically affect power since stage

o waiting times were much less than those for group 2.

Conversely, simulations in which

group 1 exhibited longer stage 0 waits had greater power when group 1 individuals with
long stage 1 waits (supporting the nUll) were most likely to be censored. This occurred
when long stage 1 waits were associated with long stage 0 waits, (i.e.) when there were
positive correlations as in variants 6 and 8.
Figures 3 and 4 provide comparisons of our test to the naive log-rank test under
both designs with total sample size N = 500, and illustrate the general inappropriateness of
the naive log-rank test for multi-stage data. Only for variants 1, 5, and 9 of design 1 were
the power curves for the naive log-rank test sensible - power increased with the difference
in marginal stage 1 waiting times, exhibited greater power than our test, and only slightly
over-inflated in size. For variants 2, 3, and 6 of design 1, in which the group 2 waiting time
correlation was strictly greater than the group 1 waiting time correlation, power was a
non-monotonic function of the difference in marginal waiting times between groups - note
that the power curves achieve minima away from the null hypothesis (1.0 on the plots). For
variants 4, 7, and 8 of design 1, in which the group 2 waiting time correlation was strictly
smaller than the group 1 waiting time correlation, the power curves were monotonic
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Figure 3. Power comparison of Zl and Zl for design 1 at N = 500
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functions of the difference in marginal waiting times between groups but exhibited greatly
inflated size. For design 2, the naive log-rank test exhibited non-monotonically increasing
power for variants 3, 4, 5, and 7 - the same variants under which our test exhibited
reduced power. Variants I, 2, 6, and 8, fo which our test showed greater power, exhibited
grossly inflated size.
From these simulations we can provisionally conclude that our test statistic Zl is an
appropriate K-sample test for waiting times in a multi-stage model, and that the log-rank
test for survival data is not an appropriate test of waiting times from a multi-stage model.
We do note that specification of the model for the censoring hazard used to generate the
inverse probability of censoring weights may have an impact on the characteristics of our
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Figure 4. Power comparison of Zl and Zl for design 2 at N = 500
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test. In our simulations, censoring times were generated uniformly across groups (according
to the Weibull(2, 5) distribution) and although our censoring hazard model specified
group-specific hazards, our test statistic performed adequately. It is likely that a
single-sample hazard model- the simple Nelson-Aalen estimator for the censoring hazard would produce similar results, (i.e.) that our test would remain appropriately sized under a
single-sample censoring hazard estimate. There has been little research into the effect of
model mis-specification on IPCW statistics, and it could be expected that bias could result
- indeed, the proofs in this and the previous chapter tacitly assume the correctness of the
specification of censoring hazard model. Additional studies could evaluate the impact of
model mis-specification on the size and power of our test statistic, as well as evaluate its
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performance under more complex multi-stage networks, although this is beyond the scope
of this dissertation.
Simulation Study - Comparison
We performed an additional simulation study comparing

Zl

to a two-sample IPCW

Mann-Whitney statistic for waiting times proposed by Fan and Datta [15]. In our notation,
the Fan-Datta test statistics can be defined as

(3.12)

In (3.12), the Ki refer to Kaplan-Meier estimators of the censoring hazard for group i. Fan
and Datta suggest the test statistic

T

= 0.5 (012j + 1 -

simulation its asymptotic normality. The need for both

021j)
012j

of symmetry in U12j caused by right censoring. In general,

and prove and illustrate via

and

012j

021j

stems from the lack

and 1 -

021j

will be close

but not necessarily equal.
For uncensored data, the log-rank test is optimal (i.e. most powerful) for alternative
hypotheses that stipulate proportional hazards (see e.g. Andersen, et aI, Sec. V.2.3 [6]).
Hence, we expect that our IPCW log-rank test statistic

Zl

will exhibit greater power than

the Fan-Datta test statistic T under proportional hazards alternatives. We designed our
simulation comparing

Zl

and T to test this expectation. The design for this simulation was

identical to the semi-Markov setup of Design 2 from the previous section. Stage 0 waiting
times, censoring times, and the correlation between stage 0 and stage 1 waiting times were
generated as in Design 2 from the previous section. In this simulation, stage 1 waiting
times, the quantity being tested, were generated from the Wei bull distribution with shape
parameter fixed at 2. The scale parameter was 2 for group 1 and ranged from 2 to 5.5 for
group 2, covering the null (scale = 2) and alternative (scale> 2) hypotheses. Note that for
a fixed common shape parameter, Weibull hazards are proportional with hazard ratio

(.At/.A2)'I', where .Ai denotes the scale parameter in group i and, the common shape
parameter. The per-group sample size for our simulated data was 100.
The results of these simulations are depicted in Figure 5. The empirical power
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Figure 5. Power comparison of

Zl

and the Fan-Datta test T
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function for the naive log-rank test Zl is plotted for reference and to further illustrate its
inappropriateness for dependent waiting times. Both test statistics maintained appropriate
size, and for large alternatives (i.e. for Weibull scale parameters 4 and greater), the power
of the two tests differed little, with our log-rank test exhibiting only slightly greater power.
The power of our log-rank test did, however, ascend more rapidly to the limiting value of 1,
and was greater than the power of the Fan-Datta test for moderately-sized alternatives
(Weibull scale parameters from 2.25 to 3.0) under several of the scenarios. Hence, for this
particular design of proportional hazards alternatives, we can reasonably conclude that our
log-rank test was more strongly powered than the Fan-Datta test, and that the gain in
power was largest for moderately-sized alternative hypotheses.
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Analysis of Burn Patient Data
To demonstrate the practical use of our test statistic, we analyzed data from a
cohort study of 154 burn patients [23]. These data are available online [26, 27] and are
described in full detail elsewhere [23, 25]. We provide a brief description here in the context
of a multi-stage model. Patients entered the study at time 0 in stage 1 for the treatment of
their burns. Subsequently, patients received one of two interventions - excision (stage 2) or
prophylactic antibiotic treatment (stage 3) - or developed staphylococcus infection (stage
4). After excision, (i.e.) entry into stage 2, patients either received prophylactic antibiotic
and entered stage 5 or developed infection and entered stage 6. Following prophylactic
antibiotic as a first treatment (entry into stage 3), patients either had their wounds excised
and entered stage 5 or developed staphylococcus infection and entered stage 7. Patients
developing infection prior to treatment (stage 4) could only have their wounds excised
(stage 6). Patients having received both treatments prior to infection (stage 5) could then
develop infection and progress to stage 8 and patients developing infection after antibiotic
(stage 7) could have their wounds excised and progress to stage 8. Stages 6 and 8 were
terminal, as stage 8 exhausts all of the events that could occur and patients in stage 6 had
already developed infection and had no need for prophylactic antibiotic treatment. Table 3
describes the stages in the model Figure 6 depicts the network structure.
We assumed that interventions (antibiotic, excision) occurred before staphylococcus
infection when the two occurred simultaneously and that interventions could occur
simultaneously. Specifically, two patients developed staphylococcus infections at the same
time as excision and were treated as having passed through stage 2 with a waiting time of
zero, while one patient that developed staphylococcus infection at the same time as

Table 3
Description of stages in multi-stage burn data model.
1.
2.
3.
4.
5.
6.
7.
8.

Onset of burn treatment
Excision of burn as first intervention
Prophylactic antibiotic as first intervention
Staphylococcus infection prior to excision or antibiotic
Excision and antibiotic (prior to infection)
Excision and staphylococcus infection (no antibiotic)
Staphylococcus infection after antibiotic, no excision
Excision, antibiotic, and staphylococcus infection
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Figure 6. Network of stages for multi-stage burn patient data
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Table 4
Observed transitions of 154 burn patients
To
From
1

2
3
4
5
6
7
8

1
24

2

3

4

5

6

7

8

~Q

Q()

')0

UU

U.:J

'-'U

1(\

()
V

()
V

()
V

33

0
12

0
0
17

14
21
0
37

6
0
11
0
17

0
6
0
0
0
2

0
0
0
8
0
4
12

.LV

receiving antibiotic was treated as having passed through stage 3 with a waiting time of
zero. Ten patients simultaneously received excision and prophylactic antibiotic and were
treated as having passed directly from stage 1 to stage 5. The data set is provided in the
Appendix.
Most patients (102 of 154) were treated by excision or antibiotic before infection
developed or before they were censored (Table 4). Among those who received excision as a
first treatment (stage 2), most were censored (33 of 53), while the majority of patients
receiving antibiotic as a first treatment next had their wounds excised (moved to stage 5,
21 of 39). For the 45 patients receiving both excision and prophylactic antibiotic prior to
infection, eight developed infection and the remainder were censored. Four of the six
patients developing infection secondary to antibiotic treatment received excision.
Twenty-nine patients reached terminal stages in the model - 17 developed infection after
excision, eight developed infection after both treatments, and 4 received excision after
prophylactic antibiotic was unsuccessful in preventing infection.
Our focus was the waiting times for patients entering stage 2, those having received
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excision as their first intervention prior to infection. We compared stage 2 waiting times
with our test statistic, Z2(t), among four groups defined by the crossing of two binary
factors in the data set: (1) receipt of routine bathing or full body cleansing, which was the
intervention in the study and (2) the experience of a respiratory burn. Fifty-three patients
entered stage 2 - Table 5 provides the distribution across the 4 groups, the transitions that
followed entry into stage 2, and the correlation between stage 1 and stage 2 waiting times.
We noted that patients experiencing respiratory burns (groups 2 and 4) were most likely to
receive antibiotic as a second intervention (i.e.) move to stage 5 after stage 2 (8 of 16),
while those not experiencing respiratory burns (groups 1 and 3) were most likely to be
censored after entry into stage 2 (28 of 37). Censoring rates were roughly equivalent for
those receiving routine bathing (12/21 = 57%) and those receiving full body cleansing
(21/32 - 66%), as were transitions into stages G ana

u.

Figure 7 depicts stage 2 waiting times and the Satten and Datta [44] estimator S2(t).
Empirically, those experiencing respiratory burns (dashed lines) exited stage 2 more rapidly
than those not (solid lines) as shown by the shorter lines in the left panel of Figure 7 and
the steeper survival function estimates in the right paneL Differences between those
receiving routine bathing (dots) and full body cleansing (triangles) were minimaL The
chi-square statistic on 3 degrees of freedom for the naive log-rank test (Z2(t)) was 7.4,
indicating marginal significance (p = .06). The chi-square statistic associated with Z2(t),
for which bootstrap res amp ling at 1000 iterations was used to estimate the variance, was
9.4, indicating a significant difference among the 4 groups (p = .02). The proximity of the
p-values for the naive log-rank test and our test suggests that the effect of potential
dependence in censoring or transition times had only a marginal effect on the comparison
of stage 2 waiting time distributions. Indeed, the Kaplan-Meier estimates of the survival

Table 5
Disposition of 53 patients observed to enter stage 2 in the burn data model

Group
1
2

3
4
All

Description
Bath, No Resp. Burn
Bath, Resp. Burn
Cleanse, No Resp. Burn
Cleanse, Resp. Burn

N
12
9
25
7
53

Next Stage
Stage 5 Stage 6 Cens.
2
1
9
4
2
3
4
2
19
1
2
4
14
6
33

39

Stage 1
Correlation
-0.40
0.13
-0.05
-0.20
-0.16

Figure 7. Stage 2 waiting times and survival functions for 4 groups of burn patients. Plotted
points represent patients who were censored. Patients presented with (dashed line) or without
(solid line) respiratory burns and received routine bathing (0) or full body cleansing (Ll).
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Table 6
Comparison of Kaplan-Meier and Satten-Datta stage 2 survival function estimates
Group 1

Group 2

Group 3

Group 4

t

S2(t)

S2(t)

t

S2(t)

S2(t)

t

S2(t)

S2(t)

t

S2(t)

S2(t)

1
9
33

0.92
0.83
0.55

0.94
0.87
0.33

3
4
8
13
14
17

0.89
0.78
0.67
0.50
0.25
0.00

0.93
079
0.66
0.53
0.31
0.00

0

0.96
0.88
0.83
0.74
0.49

0.97
0.90
0.86
0.75
0.48

0
7
10
24
35

0.86
0.71
0.57
0.38
0.00

0.78
0.66
0.54
0.34
0.00

1

7
11
25

function for each group in large part differed only slightly from the values provided by the
Satten-Datta estimator (Table 6), indicating that the effect of adjusting for censoring by
IPCW was minimal. Note also that although correlations between stage 1 and stage 2
waiting times varied over the groups, the correlations themselves were not particularly
strong (Table 5). Additionally, Groups 1 and 4 exhibited the smallest differences in
Satten-Datta and Kaplan-Meier estimates of S2(t) as well as the largest absolute rank
correlations, giving some indication that waiting time correlations do have some impact on
estimation of survival curves.
In calculating the test statistic

Z2 (t), we modeled the censoring hazard K hi (t)

as a

function of 14 time-invariant external covariates - type of bathing solution applied (routine
bath, full body cleansing), sex, race (White or non-white), percentage of body surface area
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burned, indicator functions for the presence of head, buttock, trunk, upper leg, lower leg,
and respiratory tract burns, and a four level factor accounting for the type of burn
(chemical, scalding, electrical; flame) - and time-dependent internal covariates denoting
stage occupation just before time t. This selection of covariates represents all available
covariates provided with this data set. We do note that neither interactions of covariates
nor functions of the internal stage occupation covariates were considered in modeling the
censoring hazard, mostly to avoid over-specification of the censoring hazard model. In
general, consideration of such terms requires some biological or clinical justification and we
can consider our specification to be adequate.
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CHAPTER IV
NONPARAMETRIC REGRESSION
Three of the more commonly-used regression models used for survival data are
parametric models, the semi-parametric Cox proportional hazards model [9], and the
accelerated failure time (AFT) model, with the Cox model enjoying considerable
popularity. Aalen's non parametric linear model [2, 3, 4], which we have used in previous
chapters as the estimator of the censoring hazard in multi-stage models to generate lPC\\T

estimators and test statistics, has received far less attention. As noted in the introduction,
the potential for negative hazard estimates, problems with rank-deficient regression
matrices, and the difficulty in interpreting integrated regression coefficients are likely
sources of this lack of attention. Nevertheless, as noted in our discussion of the censoring
hazard model, Aalen's model provides a very flexible alternative to the more commonly
used models. This flexibility stems from the fact that Aalen's model defines and estimates
time-varying regression coefficient functions rather than static coefficient estimates, in
addition to the allowing for time-varying covariates as the Cox model and versions of the
AFT model allow. Further, the ad hoc adjustments to hazard estimates derived fro111
Aalen's linear model noted in the introduction - fixing a lower bound of zero for the
estimated hazard and ignoring time points for which the regression matrix is of less than
full column rank - along with kernel smoothing techniques for the coefficient functions have
been suggested and generally perform well [20].
In this chapter, we define nonparametric regression coefficient estimators for waiting
times from a multi-stage model, analogous to the estimators for Aalen's linear model for
survival data. As before, we apply the IPCW principle to derive our estimators. We begin
by defining Aalen's linear model and describing estimators for waiting times from
uncensored multi-stage data. We then define IPCW coefficient estimators, derive their
martingale representation, and establish their asymptotic normality. We then conduct a
simulation study evaluating the performance of our estimators and demonstrating the
inappropriateness of the use of Aalen's liner model for survival data for multi-stage data.
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Finally, we demonstrate the use of our estimators through the analysis of a data set of 137
bone marrow transplant patients [8J. Note that we now revert back to the single-sample
notation of Chapter II.
Estimators for Uncensored Data
We begin by defining some vector and matrix notation for the counting processes
that will form our coefficient estimators. As before, we establish notation and models for
uncensored data to provide a foundation for our IPCW estimators. The introduction of
Aalen's linear model follows the notation and discussion of Andersen, et al [6], who provide
one of the more extensive treatments of Aalen's model. Although the notation of our model
for the waiting time hazard will differ from the notation for the censoring hazard model,
the formulations are equivalent. Define the individual, uncensored data stage exit and at
risk counting processes Nij(t) = f[U;'j - T;j ::; t,Xij = 1] and
~j(t) =

f[Uij - T;j ;:::: t, Xij

=

1J for 1 ::; i ::; n. Note that these individual-level counting

processes are the quantities summed to produce the aggregate counting processes from
Chapter II, (i.e.) N;(t)

=

Zi Nij(t) and }j*(t)

=

Zi ~j(t). Collect the stage j exit counting

processes into the vector Nj(t) = (Nij(t), ... , N~j(t)). Recall that the vector of covariates
for the

ith

individual is Xi(t) = (l,XiI (t), ... ,Xip(t)) and that X(t) is the n x (p+ 1)

matrix of covariates for all individuals with
covariate matrix, with

ith

ith

row ~j(t) . (1, XiI (T;j

row Xi (t). Let Y* (t) denote the "at risk"

+ t), ... ,Xip(T;j + t)).

The

ith

row of Yj(t)

provides the covariate vector for individual i multiplied by the at risk process for individual
i. Note that we have necessarily added T;j to the argument of the covariate functions X ik ,

since the covariate processes evolve in calendar time but their impact on the stage j exit
hazard only occurs after stage j entry, (i.e.) after time Tij. A matrix definition of Yj(t)
will be useful in developing our results. Abusing notation, we note that

Yj(t) = diag{(1S.j(t), ... , Y;j(t))} . X(Tj

+ t), where Tj

entry times. By this notation, we indicate that the

ith

denotes the vector of true stage j

row of X is evaluated at time T;j

+ t.

The model for the hazard of stage j exits is defined as a simple linear model, similar
to the model for the censoring hazard. At the individual level and in matrix form (again
abusing notation), we have:
P

Aij(t) = (30j(t)

+L

(3mj(t)Xim (T;j

m=I
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+ t), 1::; i

::; n

where Aj(t)

=

(A1j(t), ... , Anj(t)) and {3j(t)

=

({30j(t), . .. , (3pj(t)). Under the multiplicative

intensity model for counting processes (see, e.g. Andersen, et al [6]), we have that

N;(t) = J~ diag{Y1j(s), . .. , Y;j(s)}Aj(s)

+ M;(t),

where we define

M;(t) = (M{j(t), ... , M~j(t)) to be the vector of individual martingales associated with
stage j exits. Substituting in the expression for Aj(t) under Aalen's linear model admits
the martingale estimating equation

N;(t) =

lot Yj(s)dBj(s) + M;(t),

(4.1)

where Bj(t) = (Boj(t), ... , Bpj(t)) is the vector of integrated regression coefficients

Bmj(t) = J~ 'umj(s)cts, 0::; m ::; p; in particular, we note that dBj(t) = {3j(t)dt. Setting the
"noise" (i.e. the martingale M;(t)) equal to zero in this equation produces the estimator
for the integrated regression coefficients for uncensored data,

(4.2)
where Y;- (t) is any generalized inverse of Yj(t) and Jj (8) = J[rank(Yj(s)) = p

+ 1]

is

added to avoid complications from regression matrices of less than full column rank. The
estimator (4.2) is often referred to as a generalized Nelson-Aalen estimator, given its
functional similarity 'Nith the Nelson-Aalen estimator. In fact, when the regression matrix

X(s) is a vector of ones, the coefficient estimator (4.2) is the Nelson-Aalen estimator.
By the martingale equation (4.1), we have the martingale representation

(B; - Bj)(t) = J~ Jj(s)Yj-(s)dM;(s), which subsequently provides us with the predictable
and optional variation processes for

(B; - B
[B; - B

j )

(t)

j]

(t)

B; (t),

lot J;(s)Y;-(s) diag{Aj(s)} Yj-(s)Tds,
lot J;(s)Y;-(s) diag{dNj(s)} Yj-(s)T,

(4.3)
(4.4)

where Aj(S) = (A1j(S), ... , Anj(S)). Note that the optional variation process (4.4) serves as
an estimate of the covariance matrix for B;(t). Under suitable regularity conditions on the
matrix Y;(t), the estimator B;(t) approaches a Gaussian limit with covariance matrix
given by the expected value of the predictable variation process (4.3). For proof of this
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result, we refer the reader to Theorem VII.4.1 of Andersen, et al [6J. We do note that the
regularity conditions required of Y;(t) depend on the choice of generalized inverse, and
that Andersen, et al utilize a least squares principle and define

Yj(t)

=

(Y;(t)TY;(t)tlY;(t)T for their proofs.
IPCW Estimators

The estimator B;(t) has no use for right-censored data and the validity of estimators
based on unweighted, censored data counting processes depends on independent censoring
and the semi-Markov property. As before, to relax these requirements we propose IPCW
estimators for the integrated regression coefficients Bj(t) from Aalen's model. The IPCW
estimators are constructed just as the estimators for the stage j cumulative hazard and
survival functions from Chapter II, by replacing the counting processes from the
uncensored data estimators with IPCW analogues. Before establishing our estimators, we
define the individual IPCW counting processes Nij(t)

= I[Uij - Iij :S t, Oij = 1]/ Ki(Uij -)

for stage j exits and the IPCW stage j at-risk counting processes

+ t-)

"fij(t) = I[Uij - Iij 2: t,/'ij = I]/Ki(Tij

for 1 :s; i:S; n. Note that the Ki(t) are as

defined in Chapter II from Aalen's linear model for the censoring hazard. Define the vector

Nj(t)

=

(N1j(t), ... , Nnj(t)) and the weighted, modified coefficient matrix

Yj(t)

=

diag{Y1j(t), ... , Ynj(t)} . X(Tj

+ t).

Our IPCW estimator for the regression

coefficient vector is

Bj(t) =

lot Jj(s)Yj(s)dNj(s),

(4.5)

where Yj(t) is a generalized inverse of Yj(t) and Jj(s) = I[rank(Yj(s)) = p + IJ.
The asymptotic properties of the IPCW estimators of Chapter II and test statistics
in Chapter III relied on martingale representations and the martingale central limit
theorem. Hence, to explore the asymptotic properties of Bj(t), we establish its martingale
representation in the following lemma.
Lemma IV.1 The estimator Bj(t) defined in (4.5) has martingale representation

Bj(t) - Bj(t)

=

lot J;(s)Yj-(s)dM;(s) +
10

00

[fotYj-(s)(I - Dy(u, s)P(u))-diag{Q(u, s)}diag{dNj(S)}] x

P(u)dMC(u)

+ op(n- 1 / 2 ),
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where Dy('u, s) = fooo diag {f[u < ~l

+ sJl Ki(u)dMHu)},

+ sD/ Ki(U),

element (/[u < Uti] - f[u < Til

Q(u, s) is the vector with ith

P(u) = I - yC(u)(yc(u)Tyc(U)tlyc(u)T, and

YC(u) is the N x (p + 1) matrix diag {f[T; 2: u]} X(u).
The proof of Lemma IV.1 is a "vectorized" version of the proof of the martingale
representation of the Satten-Datta estimator Aj(t) in Lemma IIA and deferred to the
Appendix. As before, we note that this representation decomposes Bj(t) into the sum of
two orthogonal martingales, one related to the counting process for stage j exits (Mj) and
one for the counting process for censoring events (MC). Further, the first term of the
martingale representation for Bj(t) - Bj(t) is exactly the martingale representation for

Bj(t) - Bj(t), the uncensored data estimator. Due to the orthogonality of the component
martingales, when developing the asymptotic properties of Bj(t) and in particular its
predictable and optional variation processes we need not consider the covariation between
these two terms. Subsequently, the predictable and optional covariation processes can be
defined as

(Bj(t) - Bj(t»)

10

=

lot J;(s)Y;-(s) diag{Aj(s)} Yj-(s)Tds+

00

[lot yj-(s)(I - Dy( u, s)P(u»-diag{Q(u, s )}diag{ dN;(s)}] x

P(u) diag{N(u)} p(uf [lot Y;-(s)(I - Dy(u, s)P(u)tdiag{Q(u, s)}
diag{ dNj(s)}

r

du,
(4.6)

[.i3 j(t)

- Bj(t)] = lot Jj(s)Yj(s) diag{dNj(s)} Yj(S)T+

10

00

[lot Yj(s)(I - Dy(u, s)P(u»-diag{Q(u, s)}diag{dNj(s)}] x

P(u) diag{dNC(u)} p(uf [lotYj(s)(I - Dy(u,s)P(u)tdiag{Q(u,s)}
diag{ dNj(s)}r '
(4.7)
where Dy(u,s) = foOOdiag{f[u < T;j
element (/ [u < Uij ] - f [u < T;j

+ sJlKi(u)dMHu)}

+ s]) / Ki (u).

and Q(u,s) is the vector with ith

Again, we note that the optional variation

process (4.7) serves as an estimator of the variance of Bj (t), which is the in-probability
limit of (4.6).
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The martingale representation established in Lemma IV.l provides an avenue for
establishing the asymptotic normality of the IPCW integrated coefficient estimator 13j(t)
via the martingale central limit theorem. Define the in-probability limit of the predictable
variation process (4.6): ~B(t) = plimn-+oo (Bj(t) - Bj(t)). We then have the following
theorem:

Theorem IV.2 Under suitable regularity conditions,

where U(t) = (Uo(t), ... , Up(t)) is a (p

+ I)-variate

Gaussian martingale with covariance

matrix ~B(t).

The proof of Theorem IV.2 is provided in the Appendix, along with a statement of the
required regularity conditions. We again note that the conditions for the martingale central
limit theorem are the convergence of the predictable variation process to a deterministic
limit and the Lindeberg condition in which the martingale approaches a continuous limit.
For the proof of Theorem IV.2, these conditions largely focus on the regression matrix

Yj(t) and the selected form of its generalized inverse.
Simulation Study
We conducted simulation studies to evaluate the validity of the IPCW coefficient
estimator Bj(t). As in the simulation study of the waiting time log-rank statistic in
Chapter III, we considered a three-stage tracking model with individuals entering root
stage 0 and proceeded through transient stage 1 to absorbing stage 2 or were censored. We
simulated data for 100 individuals under several scenarios to evaluate the performance of

13 1 (t) - the stage 1 coefficient estimator - for discrete and continuous predictors, both fixed
and time-varying. Under each scenario, we calculated the estimate
Aalen model estimator

B1(t),

defined as

B1(t)

=

B1 (t)

IJ J1(s)Y 1(s)dN 1(s),

and the naive

where N 1(s) is the

vector of individual level censored data counting processes for stage 1 exits,

Ni1(S) = f[Ui1 - T;1 ::; s, 8il = 1], Y 1(s) is the n x (p + 1) matrix with

ith

row

Yi1(s)(I,Xi1 (S), ... ,Xip(S)) where Yi1(S) is the stage 1 at risk process for censored data
given by Yi1(S)

= f[Uil

-

Til 2: S,'Yi1 = 1], and J 1(s) = f[rank(Y1(s)) = p+ 1] is the

indicator function for the matrix Y 1(s) having full column rank. We additionally
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calculated the variance of .8(t) via the formula for the optional variation process defined in
(4.7) in order to construct asymptotic pointwise confidence intervals. We did the same for
the naive estimator B(t), noting that the optional variation process for this estimator is
J~

J 1 (s)Yl(s) diag{dN 1 (s)} Yl(s)T. The three simulation scenarios are described below.
1. Discrete, fixed covariate. For this design, we simulated data for 4 groups of

individuals, each group of size 25 and with varying stage 1 hazard. We simulated a
bivariate normal pair with marginal variance equal to 1 and covariance equal to -0.5,
0, and 0.5. The mean parameter for the first coordinate in the pair was set equal to
1, while the mean parameter for the second coordinate was set to k/4 for group k,
k

= 1, ... ,4. These pairs were exponentiated to produce correlated lognormal waiting

times for stages 0 and 1. The stage 0 and stage 1 correlations were common to all
groups, so there were three variants of this design. Censoring times were generated
from the Weibull distribution with shape parameter 2 and scale parameter 6
independently of the stage waiting times. For this design, approximately 32% of
individuals were censored before exiting stage 0 and 21 %, 25%, and 29% were
censored while in stage 1 for waiting time correlations -0.5, 0, and 0.5, respectively. A
"cell means" version of the linear hazard model under this design is

(4.8)

where the X ik are time-invariant indicators denoting membership in group k and the

i3kl(t) are the lognormal hazard functions for group k which take the form

<p(1n t - k/4)/1?(ln t - k/4), where <p and 1? represent the density and distribution
functions of the standard normal distribution.
2. Discrete, time-varying covariate. This design was identical to design 1, with the

exception that we introduced the possibility of a group switch after stage 1 entry. A
random group-switch time was generated for each individual, and at the switch time,
an individual in group 1 switched to group 4 and vice versa, and an individual in
group 2 switched to group 3 and vice versa. We generated the data for this design via
the following procedure .
• Generate the pair (Lo, Ld from the bivariate normal distribution with mean
vector (1, ILk)' where ILk is the log-mean for group k, marginal variances equal to
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1, and correlation equal to p, where p is -0.5, 0, or 0.5 depending on the design
variant being run. Exponentiate (Lo, L I ) to produce" baseline" stage

°

and 1

waiting times denoted (Wo, WI).
• Generate the group-switch times 5 from the U(0,5) distribution.
• For individuals who switched before entering absorbing stage 2 (5 < WI)'
generate the pair (La, Li) from the bivariate normal distribution with mean
vector (1, Ilk)' where Ilk is the log-mean for the group to which the individual has

switched, marginal variances equal to 1, and correlation equal to p, where p is
-0.5, 0, or 0.5 depending on the design variant being run. Exponentiate (La, Li)
to produce (WO', Wn. If the new stage 1 waiting time exceeds the switching
time (W! > 5), then W! replaces WI as the stage 1 waiting time. Otherwise,
regenerate (La, Dr) under the appropriate distribution until Wt > 5 and replace
WI with Wr

• Generate the right censoring times from Weibull distribution with shape
parameter 2 and scale parameter 6.
The cell means version of the linear hazard model under this design is similar to
design 1:

Ail (t) = ,8ll (t)Xil (1i1 + t) + ,821 (t)Xi2 (1iI

+ t) + ,831 (t )Xi3 (1i1 + t) + ,841 (t)Xi4 (1i1 + t),
(4.9)

where in this design the Xik(t) are time-varying indicators of membership in group k.
The ,8kl(t) are the same lognormal hazard functions as in (4.8), and there were 3
variants of this design based on the 3 correlation values for stage 0 and 1 waiting
times. Censoring rates under this design were the same as under design 1.

3. Continuous, fixed covariate. For this design, we simulated a simple regression model
with fixed, continuous covariate. The linear hazard model for these simulations was

(4.10)
where ,8Ol(t) was the intercept function, ,8n(t) the "slope function", and XiI the
fixed, continuous covariate. To generate these data, we simulated the pair (Lo, L 1 )
from the normal distribution with zero marginal means, unit variance, and correlation
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-0.5, 0, and 0.5, as in designs 1 and 2. We then calculated (Uo, U1 ) from the marginal

distributions of the L i , Ui = <!>i(Li), where <!> is the standard normal distribution. We
then calculated the stage 0 and 1 waiting times as Fi - 1 (Ui ), where ~-l represents the
quantile function for the exponential distribution. For stage 0 waiting times, FO- 1 was
the exponential quantile function with rate parameter 0.25. For stage 1 waiting
times, F1-

1

was the exponential quantile function with rate parameter 0.25 + {3oXi ,

where (30 took the value 0.05 and Xi represented the covariate value for patient i,
generated from the uniform distribution on the interval (-2,2). Censoring times were
generated from the Wei bull distribution with shape parameter 2 and scale parameter
6. Under this design, 33% of all individuals were censored before stage 1 entry, and
36%, 32%, and 27% of individuals were censored while in stage 1 for stage waiting
time correlations -0.5, 0, and 0.5, respectively. The function

POI (t) was the constant

function 0.25 (the exponential hazard rate) and the function (311 (t) the constant
function 0.05.
Under each design, censoring times were generated independently of stage waiting times
and uniformly for all individuals. Hence, we used the Kaplan-Meier estimator to estimate
the probability of censoring Ki(t) for the inverse probability of censoring weights. One
thousand Monte Carlo iterations were run for each variant of each design.
Before conducting a detailed examination of the performance of the IPCW and naive
coefficient estimators, we briefly take an empirical look at the raw results of our
simulations. Figures 8 and 9 depict the IPCW and naive estimates for selected regression
coefficients and variants of designs 1 through 3 (row 1 through 3 respectively). Variants in
which stage 0 and 1 waiting times were negatively correlated are plotted in the left column
and variants with positive correlation in the right column. The selected regression
coefficients for each design are noted in the y-axis label of each panel of each plot. The
IPCW estimator appeared approximately in all situations, but did exhibit greater variance
than the naive estimator as illustrated by the greater scatter in the integrated coefficient
estimators. The naive estimator seemed to underestimate the true integrated regression
coefficient functions for variants in which stage waiting times were negatively correlated most of the estimated integrated regression functions were below the true values.
Conversely, the naive estimator overestimated the true regression coefficients when stage
waiting times were positively correlated. We do not show plots from variants in which stage
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Table 7
Average bias for IPCW and naive coefficient estimators, simulation designs 1 and 2
DesignVariant

Corr.

t

13ll(t)

1-1

-0.5

2
4

0.037
0.061

0.012
0.072

-0.007
-0.059

0.008
0.063

-0.244
-0.247

-0.209
-0.191

-0.198
-0.213

-0.149
-0.176

1-2

0

2
4

0.019
0.010

0.022
-0.007

0.015
-0.047

0.003
-0.018

0.009
-0.009

0.011
-0.028

0.000
-0.046

0.000
-0.009

1-3

0.5

2
4

0.033
0.033

0.020
-0.026

-0.008
-0.031

-0.023
-0.054

0.325
0.187

0.280
0.170

0.215
0.129

0.151
0.091

2-1

-0.5

2
4

-0.064
-0.029

0.008
-0.017

0.008
-0.062

0.048
0.054

-0.270
-0.534

-0.187
-0.393

-0.134
-0.240

-0.091
-0.138

2-2

0

2
4

-0.069
-0.039

0.010
-0.020

0.012
0.010

0.023
-0.037

-0.066
-0.396

-0.004
-0.231

0.010
-0.103

0.035
-0.040

2-3

0.5

2
4

-0.044
-0.052

-0.024
-0.033

0.003
-0.019

-0.028
0.011

0.149
-0.257

0.190
-0.101

0.185
0.024

0.179
0.064

IPCW Estimator
13 21 (t) 1331 (t) 1341 (t)

Bll(t)

Naive Estimator
B21 (t) B31 (t)

B41 (t)

waiting times were uncorrelated, but do note that both the IPCW and naive estimators
appeared approximately unbiased.
To further investigate the bias and variance associated with each estimator, we
selected interim time points at which to calculate the integrated coefficient estimates and
associated asymptotic 95% confidence intervals, times t = 2 and t = 4. In Table 7, we
present the average bias of our IPCW coefficient estimator and the naive coefficient
estimator for each variant of simulation designs 1 and 2. The IPCW estimator was
approximately unbiased for each variant - the biases for (31 (t) listed in Table 7 represent
less than 6% of the true values at the given time points. While overestimation was more
likely at time t = 2 (14 of 24 estimates) and underestimation at time t = 4 (14 of 24) for
the IPCW estimator, this pattern was not consistent over groups or variants. The naive
estimator was approximately unbiased for variant 2 of designs 1 and variant 2 of design 2
at time t = 2, for each of which the waiting time correlation parameter was O. The naive
estimator underestimated the true hazard at time t = 4 for variant 2 of design 2, where
stage waiting times were uncorrelated.
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Figure 8. IPCW coefficient estimators for selected variants of simulation designs 1-3. The
left/right column plots variants with negatively/positively correlated waiting times (denoted
by -/+). Design 1 estimates are plotted in row 1, design 2 in row 2, and design 3 in row
3. Sixty Monte Carlo iterates are plotted in each, and regression coefficient estimator is
identified by the y-axis label. True cumulative hazard estimates for each model parameter
are plotted with a solid line.
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Figure 9. Naive coefficient estimators for selected variants of simulation designs 1-3. The
left/right column plots variants with negatively/positively correlated waiting times (denoted
by -/+). Design 1 estimates are plotted in row 1, design 2 in row 2, and design 3 in row
3. Sixty Monte Carlo iterates are plotted in each, and regression coefficient estimator is
identified by the y-axis label. True cumulative hazard estimates for each model parameter
are plotted with a solid line.

Naive Estimator
4

4

o

2

3

4

o

5

4

4

3

3

..

~

~

'"

len.

S

2

len.

I

0

2

3

5

4

+

I

2

3

4

5

2

3

4

5

+

2

0
0

6

2.0

4

6

+

1.5
3
1.0
~

~

~
0

len.

2

~

1c:2i:

0.5
0.0
-0.5
-1.0

0
0

2

4

6

8

0

10

53

2

4

6

8

10

Table 8
Coverage probabilities for asymptotic 95% CI, simulation designs 1 and 2

Corr.
-0.5

t
2
4

IPCW Estimator
Bll (t) B2dt) 13 31 (t) B41 (t)
0.955 0.960 0.960 0.951
0.947 0.950 0.954 0.953

1-2

0

2
4

0.961
0.952

0.967
0.948

0.961
0.955

0.951
0.956

0.954
0.950

0.960
0.954

0.957
0.956

0.959
0.970

1-3

0.5

2
4

0.953
0.967

0.957
0.966

0.961
0.962

0.956
0.960

0.913
0.950

0.909
0.880

0.914
0.901

0.910
0.873

2-1

-0.5

2
4

0.961
0.945

0.955
0.954

0.954
0.966

0.944
0.953

0.850
0.852

0.904
0.887

0.934
0.937

0.947
0.966

2-2

0

2
4

0.962
0.933

0.951
0.954

0.950
0.963

0.946
0.960

0.950
0.923

0.959
0.919

0.962
0.913

0.955
0.906

2-3

0.5

2
4

0.965
0.947

0.954
0.953

0.951
0.963

0.946
0.961

0.940
0.849

0.921
0.850

0.917
0.946

0.908
0.946

DesignVariant
1-1

Naive Estimator
13ll(t) 13 21 (t) 13 31 (t) 13 41 (t)
0.922 0.888 0.832 0.863
0.796 0.813 0.837 0.831

The naive estimator additionally exhibited substantial bias when stage 0 and 1
waiting times were correlated - (31(t) underestimated the true cumulative hazard for
negatively correlated waiting times and overestimated for positively correlated waiting
times. This bias pattern was reasonable for our designs. When waiting times were
negatively correlated, longer stage 1 waiting times - which signified lower hazard - were
less likely to be censored since they were associated with shorter stage 0 waiting times.
Conversely, shorter stage 1 waiting times - which signified greater hazard - were more
likely to be censored, being associated with longer stage 0 waiting times. These effects led
to the underestimation of the stage 1 cumulative hazard function. An opposite effect was
seen for positively correlated stage waiting times - shorter stage 1 waiting times (greater
hazard) were more likely to be censored being associated with shorter stage 0 waiting times
and vice versa leading to overestimation of the stage 1 cumulative hazard. The presence of
a time-varying covariate did not have a substantial impact on the bias exhibited by the
IPCW and naive estimators - there were no consistent patterns in bias when comparing
designs 1 and 2.
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Table 9
Bias and coverage probabilities for asymptotic 95% CI, simulation design 3

t

IPCW
Ell (t) B21 (t)

Naive
13 11 (t) 13 21 (t)

Coverage Probability
IPCW
Naive
Ell (t) E21 (t) 13ll(t) 13 21 (t)

2
4

0.032
-0.030

0.007
0.006

-0.160
-0.259

-0.021
-0.024

0.937
0.938

0.936
0.952

0.476
0.623

0.913
0.917

0

2
4

0.006
0.011

0.001
0.008

0.000
-0.006

0.002
0.009

0.953
0.958

0.944
0.954

0.944
0.957

0.947
0.957

0.5

2
4

-0.028
0.008

0.001
-0.009

0.180
0.401

0.029
0.100

0.965
0.974

0.942
0.968

0.730
0.998

0.892
0.997

Bias

DesignVariant

Corr.

3-1

-0.5

3-2

3-3

Table 8 provides coverage probabilities for the nominal asymptotic 95% confidence
intervals for the IPCW and naive estimators. Confidence intervals for the IPCW estimator
were close to the nominal 95% level and, if anything, were slightly overly conservative.
Coverage probabilities were fairly consistent with no apparent patterns over the designs,
variants, or selected time points. Confidence intervals for the naive estimator were at the
nominal level for variant 2 of designs 1 and 2 (no correlation between stage 0 and 1 waiting
times), but provided generally did not provide nominalcoverage when waiting times were
correlated. This aberrant coverage generally can be attributed to the bias associated with
naive estimator. Coverage of the naive confidence intervals was generally poorest when the
true hazard was underestimated. The coverage bias was lower for overestimated hazards,
partly because the variance of the naive estimator is a function of the cumulative hazard
itself. Hence, when hazards were overestimated, variances tended to be overestimated,
partially (but not completely) correcting the bias in the confidence intervals. Again, the
presence of a time-varying covariate seemed to have no impact on the observed coverage of
the naive and IPCW confidence intervals, as no patterns emerged when comparing coverage
rates for designs 1 and 2.
Table 9 provides the bias and coverage probabilities for the IPCW and naive
estimators for variants of design 3. The IPCW was approximately unbiased for all variants
of design 3 - the bias estimates in Table 9 represent less than 8% of the true coefficient
estimates. The coverage probabilities associated with the asymptotic confidence intervals
for the IPCW estimator were close to the nominal 95% level. The intervals tended to
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exhibit less than nominal coverage for variant 1, where waiting times were negatively
correlated, and greater than nominal coverage for variant 3, where waiting times were
positively correlated. The naive estimator was unbiased and its asymptotic confidence
intervals close to the nominal level only when waiting times were uncorrelated (variant 2).
As noted in the empirical examination (Figure 9), the naive estimator underestimated the
true integrated regression coefficient function when stage waiting times were negatively
correlated (variant 1), and overestimated the true integrated regression coefficient function
when stage waiting times were positively correlated (variant 3). The bias estimates in Table
9 were as high as 50% of the true values for the naive estimator. The coverage exhibited by

the asymptotic confidence intervals for the naive estimator was poor. Interestingly, at time
t = 4 for variant 3 the naive confidence intervals exhibited over-coverage, with probabilities

approaching 1. vVe again note that the asymptotic variance of the naive estimator is a
function of the estimated hazard - overestimated hazards are in turn accompanied by
overestimated variances, which partially explains the overcoverage of these intervals.

Analysis of Bone Marrow Transplant Data
To demonstrate the use of our regression coefficient estimator for waiting times, we
analyzed data from an intervention study 137 bone marrow transplant with acute
myelocytic leukemia (AML) and acute lymphoblastic leukemia (ALL) [8]. All patients in
the study were treated with a regimen of bulsufan 4 mg/kg over 4 days and
cyclophosphamide 60mg/kg over 2 days followed by bone marrow transplantation from a
sibling. Following transplantation, patients were tracked and the time to five events were
noted - return of platelet counts to a sustainable level, onset of acute
graft-versus-host-disease (GVHD), onset of chronic GVHD, relapse of AML or ALL, and
death. Data for additional prognostic indicators and treatment characteristics were
collected - patient age, sex, and cytomegalovirus (CMV) status (positive or negative),
donor age, sex, and CMV status, waiting time to transplant, the French-American-British
(FAB) classification of morphological status, treating hospital, and administration of a
prophylactic combining methotrexate (MTX) with cyclosporin and (possibly)
methylprednisolone. These data are available online [26, 27] and are described in further
detail elsewhere [8, 25].
The stages in the multi-stage model are described in Table 10 and depicted in Figure
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Table lO
Description of stages in multi-stage bone marrow transplant model.

1.
2.
3.
4.
5.
6.
7.

Bone marrow transplantation
Acute GVHD as first event
Platelet recovery as first event
Platelet recovery secondary to acute GVHD
Acute GVHD secondary to platelet recovery
Chronic GVHD
Death or relapse of AMLj ALL

10. After transplantation (stage 1, time 0), patients either developed acute GVHD (stage
2), exhibited platelet recovery (stage 3), developed chronic GVHD (stage 6), or relapsed or
died (stage 7). Patients initially developing acute GVHD (stage 2) could then experience
platelet recovery (stage 4), develop chronic GVHD, or relapse or die in any sequence
allowed by the model. Similarly, patients initially exhibiting platelet recovery (stage 3)
could then develop acute GVHD (stage 5), develop chronic GVHD, or relapse or die in any
sequence allowed by the model. Note that we have defined the multi-stage model in this
fashion, with two orderings of platelet recovery and acute GVHD, so that the defined
network was acyclic. More extensive models are possible by considering distinct orderings
of these platelet recovery, acute GVHD, and chronic GVHD, but paths under such
orderings would exhibit sparse sample sizes. Further, we note that follow-up continued for
patients that relapsed prior to death and times to the other events (platelet recovery, acute
GVHD, chronic GVHD) were tracked. However, we treated death or relapse as an
absorbing stage and gave no further consideration of events occurring after death or relapse.
The observed transitions for these data are provided in Table 11. The vast majority
of patients (117) experienced platelet recovery immediately following transplantation
(entered stage 3 from stage 1), and very few (7) experienced acute GVHD initially. Overall,
platelet levels recovered for 120 patients, twenty-six patients developed acute GVHD, and
fifty-nine developed chronic GVHD. Eighty-three of the 137 patients (61%) were followed
until death or relapse, with twenty patients censored after platelet recovery (in stage 3),
two after acute GVHD secondary to platelet recovery (in stage 5), and thirty-two after the
onset of chronic GVHD (in stage 6).
The focus of our analysis was on waiting times in stage 6, the time from onset of
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Table 11
Observed transitions of 137 bone marrow transplant patients

From
1
2
3
4
5
6
7

1
0

2
7
0

To
4
0
3
0
0

3
117
0
20

5
0
0
19
0
2

6
1
2
44
1
11
32

7
12
2
34
2
6
27
83

Figure 10. Network of stages for multi-stage bone marrow transplant data
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chronic GVHD until death or relapse. We modeled stage 6 cumulative hazards as a
function of one continuous internal covariate, the time to onset of chronic GVHD after
transplantation, one continuous external covariate, patient age, and one three-level discrete
external covariate, patient disease group (ALL, low risk AML, high risk AML). Letting

-Xi6

denote the hazard of stage 6 exit for patient i, our model for this analysis was

(4.11)
In this model, we selected the ALL disease group to be the baseline group, and
XiI =

Ti6 - Til

represented the time to stage 6 entry, X i2 represented patient age at

transplantation, X i3 was an indicator for low risk AML, and X i4 an indicator for high risk
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AML. This model provides information on whether patient age and the time to onset of
chronic GVHD impacted the risk of death or relapse after chronic GVHD onset, and
whether differences in death or relapse hazard after chronic GVHD hazard were observed
between disease groups. Our motivation for this specification was to include a variety of
types of covariates - continuous and discrete, internal and external.
To construct the inverse probability of censoring weights necessary for our analyses,
we modeled the censoring hazard via Aalen's linear model as a function of 14 fixed external
covariates mentioned above - patient disease group (ALL, low risk AML, high risk AML),
patient age, sex, and cytomegalovirus (CMV) status (positive or negative), donor age, sex,
and CMV status, waiting time to transplant, an indicator function for the FAB
classification of morphological status (1 if FAB grade was 4 or 5 and the patient had
AML), a categorical factor for the treating hospital, and an indicator representing
administration of a prophylactic combining methotrexate (MTX) with cyclosporin and
(possibly) methylprednisolone. Additionally, we included a 6-vector of internal covariates
denoting stage occupation at time t. This model specification exhausted all covariates
included in the data set. Interactions among the external covariates and extended functions
of the internal covariates were not included in the censoring hazard model to avoid model
over-specification and for lack of biological justification.
Of the 59 patients developing chronic GVHD, twenty had ALL, eight of whom died
or relapsed, 21 had low risk AML (9 deaths or relapses), and 18 had high risk AML (10
deaths or relapses). The average age was 28 years, which ranged from 11 to 50, and the
median time to chronic GVHD was 140 days (min = 76, max = 487). Figure 11 provides
an empirical look at the data in the context of our model, plotting stage 6 waiting times
against each of the covariates in model (4.11). We noted that longer times to chronic
GVHD were seemingly associated with longer times to death or relapse after chronic
GVHD onset, although the association was not strict and came with substantial variability.
There appeared to be no relationship between patient age and the post-chronic GVHD
time to death or relapse, and the disease groups did not appear to significantly differ with
respect to post-chronic GVHD time to death or relapse.
The results of our analysis for model (4.11) are depicted in Figure 12 and confirmed
empirical observation of Figure 11. The intercept term, had little clinical interpretation
and is not plotted, representing the cumulative hazard of ALL patients with zero values for
the continuous covariates (age and time to chronic GVHD). We first noted that all stage 6
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Figure 11. Plots of stage 6 waiting times against covariates included in model (4.11) - time
to chronic GVHD onset, patient age, and disease group. Filled points represent observed
deaths or relapses and open points represent censored observations.
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exits occurred within 1000 days upon stage 6 entry and that relatively few observations
were censored prior to 1000 days (plotted points in Figure 12). Hence, we can conclude
that the patients not having died or relapsed after 1000 days of observation were at
negligible risk of death or relapse. Further, only two exits from stage 6 occurred after 600
days, so that the risk of relapse or death 600 days after chronic GVHD onset was low.
The regression coefficient B16(t) progressed in a negative direction, indicating that
patients with longer waiting times to chronic GVHD onset experienced a reduced hazard of
death or relapse (i.e. longer stage 6 waiting times) after chronic GVHD onset. This effect
was apparently significant, judging by the pointwise 95% confidence limits which excluded
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the null value 0 beyond 200 days after chronic GVHD onset. A normal test of the integrated
regression coefficient B16(t) at the end of observation (day 2102, the last censoring time)
was strongly significant (z = 3.59,p = .0003). Patient age at transplantation had no
apparent effect on the risk of death or relapse secondary to chronic GVHD. The integrated

B26 (t)

coefficient function

was non-monotonic and remained close to zero, with large

Figure 12. Estimates of integrated regression coefficients from model (4.11) of bone marrow
transplant data. The IPCW estimate is provided by a solid line, the naive estimate by a
dotted line, and approximate pointwise 95% CI for the IPCW estimate by dashed lines.
Plotted points are censored waiting times.
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confidence intervals containing 0 over all observed waiting times. The normal test of

B26 (t)

was non-significant (z = 0.63,p = 0.53). The low risk and high risk AML groups were at
greater risk of death or relapse secondary to chronic GVHD, as shown by the positive
integrated regression coefficients

B36 (t)

and

B46 (t).
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However, these differences were small

relative to the variability of the hazard estimates and were non-significant based on a
normal test (low risk AML: z = l.31,p = .19; high risk AML: z = 0.92,p = .36).
Additionally, a comparison of all three groups was non-significant

(xi

= 2.57,p = .11).

The IPCW regression coefficient estimates did not substantially differ from the naive
estimates (dotted lines, Figure 12). The maximum differences between the IPCW and
naive estimates of the five integrated regression coefficients (intercept included) were 0.12,
0.0003, 0.0019, 0.06, and 0.02, respectively. These maximal differences occurred at or close
to the largest stage 6 waiting times and represented less than 10% of the IPCW coefficient
estimates. These small differences in estimates suggested that any dependencies among
censoring and transition times had a minimal effect on our marginal analysis of stage 6
waiting times.
From a clinical perspective, our results demonstrated that neither patient age nor
disease group (ALL, low risk AML, high risk AML) were significant determinants of the
risk of death or relapse following the onset of chronic GVHD. Previous analyses [25J of
these data demonstrated that low risk AML patients exhibited significantly lower hazard of
death or relapse than ALL and high risk AML patients, both marginally and after
adjusting for patient age (which was non-significantly associated with the death/relapse
hazard). However, the results of this analysis have little bearing on our present analysis, as
it considered death/relapse hazards after transplantation, (i.e.) the hazard of death/relapse
from stage l. We have additionally demonstrated that patients who more rapidly
developed chronic GVHD exhibited significantly greater hazard of death or relapse after
chronic GVHD onset. It would be reasonable to speculate, then, that patients with rapid
onset chronic GVHD should be closely monitored for the risk of death or relapse. We note
that there was some covariation among our selected predictors. Among the 59 patients that
developed chronic GVHD, patient ages significantly differed (Kruskal-Wallis test, p

=

.005), with the ALL group exhibiting lower ages (mean age = 23) than the low an high risk
AML groups (mean ages 30 and 31, respectively). Further, the time to onset of chronic
GVHD was significantly different among groups (Kruskal-Wallis test, p = .02) - ALL
patients most rapidly developed chronic GVHD (median wait = 120 days), followed by
high risk AML patients (150 days) and low risk AML patients (180 days). Patient age and
time to chronic GVHD onset were marginally significantly related (Spearman correlation =
0.23, p = .07). However, our empirical inspection of the association between stage 6
waiting times (Figure 11) and our model covariates seemed to illustrate no marginal
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association between patient age, disease group, and stage 6 waiting times, and we so
suspect no confounding relationships among our covariates.
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CHAPTER V
CONCLUSION
In this research, we have applied the principle of inverse probability of censoring
weighting (IPCW) to develop K-sample test statistics and non parametric regression
coefficient estimators for waiting times from multi-stage models. In Chapter III, we
introduced K -sample test statistics for waiting times in a multi-stage model that were
analogous to traditional test statistics for survival data, such as the log-rank test. The

simulation studies we conducted demonstrated that our test statistics, via the IPCW
approach, were robust against violations of the typically-required assumptions of
independent censoring and the semi-Markov property. Further, the simulations
demonstrated that test statistics for survival data were generally inappropriate for waiting
times from a multi-stage model, exhibiting inflated size and non-monotonic relationships
with the effect size implied by the alternative hypothesis. The simulations also illustrated
that our test statistic exhibited greater power than a generalized IPCW Mann-Whitney
statistic for waiting times under proportional hazards alternatives. This corresponded with
the well-known result for survival data that log-rank tests are optimal for proportional
hazards alternatives.
In Chapter IV, we introduced a nonparametric regression model for waiting times
corresponding to Aalen's linear model for survival data. Our simulation studies in Chapter
IV demonstrated that the IPW coefficient estimator was approximately unbiased in several
situations, particularly under violations of the semi-Markov property. Further, as expected,
the unadjusted, naive coefficient estimators exhibited substantial bias when waiting times
from successive stages in the multi-stage model were correlated. These results were
contemporary with the results of the simulation study of the hypothesis test statistic - that
IPCW statistics perform adequately under violations of the typical assumptions made of
multi-stage models and the statistics adapted from survival data can be significantly biased.
A significant advantage of the IPCW approach is its relative simplicity. As
frequently noted above, the IPCW principle itself is quite simple - replacing the
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uncensored data counting processes used for traditional estimators with their IPCW
equivalents. Hence, armed with reasonable estimates of the probability of censoring, IPCW
estimators and test statistics are fairly simple to construct. However, calculating estimates
of the probability of censoring to use as weights can be fairly complicated and requires
some attention. A detailed analysis of censoring patterns should be conducted before
generating the weights for IPCW statistics, particularly in the context of a multi-stage
model. Such an analysis would ensure that as accurate an estimate of censoring
probabilities is generated. In some capacity, the complexity of such a preliminary analysis
of censoring patterns is related to the complexity of the multi-stage network, particularly if
stage-dependent censoring is suspected. Nevertheless, the IPCW statistics we have
introduced were of closed form and calculable from the available data as were estimates of
variance, regardless of the observed censoring patterns.
Another advantage of the IPCW approach is its generality. The IPCW principle of
replacing uncensored data counting processes with IPCW analogues applies directly to
waiting times from multi-stage data just as with survival data, for which it was initially
developed. The IPCW method does not make unnecessary assumptions about censoring
patterns nor the independence of transition times from a multi-stage model. Further, the
proof of the asymptotic equivalence of IPCW counting processes and uncensored data
counting processes was independent of the method used to estimate the probability of
censoring, (i.e.) the proofs were based on any estimate of the probability of censoring
rather than a particular estimates. Therefore, any asymptotically consistent estimator of
the probability of censoring can be used. Our use of Aalen's linear model for the censoring
hazard was predicated by the unique flexibility it possesses via its coefficient functions. We
do recall that the selection of estimate for the probability of censoring does playa role in
the asymptotic distribution of IPCW statistics, but this dependence largely impacted
expressions for the asymptotic variance and estimators thereof.
Aalen's linear model has received only minimal attention, and to our knowledge the
results of Chapter IV are the first attempt at extensions under dependent censoring or for
multi-stage models. As noted in the introduction, there are several methods for hypothesis
testing of survival times and waiting times from a multi-stage model under dependent
censoring. We note that the test statistics of Lin, Robins, and Wei [31], Lin and Ying [33],
and Fan and Datta [15] were developed explicitly for two populations, whereas our
proposed test statistics apply to K > 2 populations. The regression estimators by several
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authors detailed in the introduction can provide tests for K > 2 populations as well. The
IPCW U-statistic proposed by Datta, et al [10] provide a very general result with broad
applicability. In the same way many common statistics from classical statistics can be
expressed as traditional U -statistics, we expect that many IPCW statistics and estimators
have representation as IPCW U -statistics.
As noted in Chapter II, the IPCW principle has been previously applied to develop
estimators of the cumulative hazard and survival functions for waiting times in a
multi-stage model [44]. In this research, we have developed K-sample log-rank-type test
statistics and nonparametric regression estimators. Each of these statistics are analogous to
their survival data counterparts - the Nelson-Aalen estimator for cumulative hazards, the
Kaplan-Meier estimator for survival functions, the log-rank test, and Aalen's linear model.
As noted earlier, perhaps the most popular regression model for censored survival data is
the Cox proportional hazards model [9]. The Cox model specifies a multiplicative hazard
function, in which the hazard of an event is modeled as the product of a "baseline" hazard
function and an exponentiated linear combination of model covariates. While IPCW
estimators akin to those from the Cox model have been developed for censored survival
data, extensions to waiting times from multi-stage models have not been pursued. This
provides an avenue for further research, and we briefly motivate it below.
In our notation, the Cox model adapted to waiting times from a multi-stage model
specifies the multiplicative hazard function

(5.1)
where AOj(t) denotes a baseline hazard for stage j exits and {3 is the vector of regression
coefficients. (A more general formulation, referred to as a "relative risk" model, replaces
the exponential function with a general risk function r({3, Xi).) Again, we note that the
covariate vector is evaluated at Ii;

+ t since the covariate processes evolve in calendar time

but our interest is in modeling what occurs after stage j entry. The baseline hazard AOj(t)
is left completely unspecified. Omitting the details of the derivation (see Andersen, et al [6]
for a detailed treatment), the coefficient vector (3 is estimated as a solution to the score
equation

U~({3) =

0, where
U~({3)

n

r

r

= ~ 10 Xi(Iij + t)dNij(t) - 10 E({3, t)dN;(t),
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(5.2)

where the covariate vectors Xi(t) and stage j uncensored data counting process Nij(t) and

N;(t) are as defined in the text,

T

represents a sufficiently large time point to accumulate

all exits from stage j, and the vector E*(,6, t) is
*
8(1)*(,6, t)
E (,6, t) = S(O)*(,6, t)'

(5.3)

where
n

L exp (,6TX i(I:j + t)) ~j(t)
i=l
n

8{l)*(,6, t)

L Xi(I:j + t)exp (,6TXi(I:j + t)) ~j(t),

(5.4)

i=l

and the

}~;

are the uncensored data stage j at risk processes. The covariance matrix of the

estimator ,6* arrived at via the score equation (5.2) can be estimated by 1;(,6), where
1;(,6)

=

loT V*(,6, t)dN;(t),

(5.5)

where V*(,6, t) = 8(2)*(,6, t)/S(O)*(,6, t) - E*(,6, t)E*(,6, t)T, and
n

8(2)*(,6, t) =

L Xi(I:j + t)Xi(I:j + t)Texp (,6TX (I:j + t)) ~j(t).
i

(5.6)

i=l

Finally, the baseline cumulative hazard AOj(t) = J~ AOj(s)ds can be estimated by
(5.7)
where J;(s) = J[Yj*(s) > 0].
Under suitable regularity conditions on the functions S(O)*, 8(1)*,8(2)*, E*, and V*, it
can be shown that a solution ,6* to U;(,6) = 0 exists and is unique with probability
approaching 1 and ,6* converges in probability to the "true" value of the covariate vector
(see Condition VI1.2.1 and Theorem VI1.2.1 of Andersen, et al [6]). Under an additional
Lindeberg assumption on the covariate processes Xi(t), the covariate estimator ,6* can be
shown to be asymptotically normal with covariance matrix consistently estimated by
n- l l;(,6*) (see Condition VII.2.2 and Theorem VII.2.2 of Andersen, et al [6]). A similar
weak convergence result holds for the estimator (5.7) of the cumulative baseline hazard
function.
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As expected, the applicability of the Cox model for right censored survival data
hinges in some part on the independence of censoring times from survival times. Further, a
waiting time Cox model would require independent censoring and the semi-Markov
property. We therefore propose IPCW estimators of the model coefficients and baseline
cumulative hazard function for waiting times in a multi-stage model. As before, the
definition of these estimators is simply the replacement of uncensored data counting
processes in the uncensored data estimators with their IPCW equivalents. In detail, define
the following quantities:
n

L exp (rPXi(Iij + t)) Jlij(t)
i=l
n

L Xi(Iij + t)exp (rPXi(Iij + t)) Jlij(t)
.

~1

n

L

Xi(Iij

+ t)Xi(Iij + tfexp (rPXi(Iij + t)) Jlij(t)

i=l

Eca, t)

8(1)(,6, t)
§0(,6, t)

~ foT Xi(Iij + t)dNij(t) - foT E(,6, t)dNj(t),

(5.8)

where Nij , N j , Jlij , Y:; are the stage j exit and at risk IPCW counting process defined before.
We then suggest IPCW estimators

j3 as the solutions to the score equation U (,6) = O.

We

T

additionally suggest an IPCW estimator for the baseline hazard function

~ .t A
0) ( ) -

lot §CO)].(s)
)
(,6, s) dN·) (s ),

(5.9)

0

where Jj(s) = J[Y:;(s) > 0].
The consistency and asymptotic normality proofs for the estimator ,6* for
uncensored data partially rest upon a martingale representation for the score function. In
particular, the kth component of the score vector U t(,6) has representation

(5.10)
where the X ik and E'k are the components of Xi and E*, respectively, and k

= 1, ... ,p.

A

related martingale representation for the baseline hazard estimator is also the foundation
for the proof of its asymptotic normality. We expect that a martingale representation for
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the IPCW score function U T (,I3) can be achieved and asymptotic results derived therefrom.
The martingale representations we derived for IPCW statistics in this dissertation
decomposed into the sum of two orthogonal martingales - (1) a stochastic integral of a
predictable process with respect to the martingale associated with the uncensored data
counting process for stage j exits, and (2) a stochastic integral of a predictable process with
respect to the martingale associated with the counting process for censoring events.
Further, the first martingale of these decompositions corresponded directly to the
martingale associated with a given uncensored data estimator/test statistic. Based on these
results, we expect that such a decomposition could be achieved for the IPCW score process
U T (,I3), and that the first summand of said decomposition would be precisely the score
process U;(,I3). Further, we expect that the asymptotic variance of IPCW Cox model-type
estimators would be the sum of the uncensored data variance expression I; (,13) and the
predictable covariation process of the second martingale of the decomposition.
For asymptotic considerations, the conditions required for the consistency of fj
would include those conditions required for ,13*, but would likely require additionally
assumptions guaranteeing the asymptotic negligibili,ty of the second martingale from the
decomposition. Similarly, the conditions required for asymptotic normality of fj would
include those for ,13* but would require additional assumptions on the second martingale,
Practically speaking, these weak convergence assumptions will likely be a function of the
method of estimation for the inverse probability of censoring. For our results, they were
regularity conditions on the vector of covariates used to estimate the censoring hazard via
Aalen's linear model. These concepts, of course, need more formalization and investigation,
but do provide a fruitful direction for additional research into inference for multi-stage
models under dependent censoring and violations of the semi-Markov property.
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APPENDIX
Proofs of Lemmas and Theorems
Proof of Lemma

II.4·

We first note that Aj(t) - Aj(t) can be decomposed as follows:

rt

~d(Nj(s) _ N;(s))
10 Yj(s)
rt dN;(s) . , '
Jo Yj:(s) - i\jlt).

+

it (~_
Yj(s)
0

y*l( )) dNj(s)

j s

+
(A.I)

Denote the three summands of the right hand side of (A.l) sum as I, II, and III. By
standard martingale methods, we then have that
III

where where J;(s)

=

t J*(s)
_J_'-dM*(s)
o Yj*(s)
J

i

+ 0 (n- 1/ 2 )
P

(A.2)

,

= I[Yj*(s) > OJ. We note that ~9j(t) = Sj(t) + op(n- 1/ 2 ), by the

following chain of argument: (1) 9j(t) ~ Yj(t) by the consistency of B(t) under Aalen's
linear model, (2) Yj(t) = Y*(t)

+ op(n- 1/ 2 ) hy Theorem ILl, (3)

~}j*(t) ~ Sj(t) by the

law of large numbers. Hence, we have that the first term satisfies

"

n

~

1=1

1
(I[U~.tJ_- T*·1) <
tJ5··1)
nS.(U*.
T*.)
K(U
..
-)
J
lJ
tJ
t
lJ

_

I[U*. _ T':. < t X· =
tJ

lJ -

,

lJ

IJ ) + 0 P (n-1/2)

Using Lemma II.2 (and the note directly following it), the consistency of K i , and the law of
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large numbers, we get

_.;:... I[Utj - ~j S t]1>j
L.....
i=l
nSj(UiJ - ~J)

_

-

We next note that ~N~(t) = 1 - SAt)
that ~Yj(t)

=

Sj(t)

+ op(n- 1/ 2 ).

roo l[s < Uij] dM-C() + op (-1/2)
n
.

ln0

+ op(n- 1/ 2 )

(A.3)

S

Ki(S)

1

by the same chain of argument asserting

We now observe that

By Lemma 11.2, the consistency of K i , and the law of large numbers we have
II =

_

';:'' I 1[Uij - ~j ~ s]1>j 1
t

L.....
i=l

Tij

S2( )
n j S

0

+

0

s
-

_I_ dM
- C(

K.()
1 U

1

)

U

dS.( ) +
J S

op

(-1/2)
n

.

Interchanging the order of integration on the right hand side produces
I

I

=

r .)

n
T*.+t~
f;;;;.lo

{tr

lOV(S-Tij)

I[U*ij - T*ij >
]1>.J
- U

nSJ(u)

.()
U

dSJ

} _1_ -C( )

(-1/2

Ki(s)dMi S +op n

)

where

.. (

91J S,

)_
t -

1>j ( 1[s - t < ~j]
_
l[s - t < ~j]
)
.
nKi (S ) Sj (t 1\ (UiJ - ~J) )
Sj ((0 V (s - T iJ )) 1\ (UiJ - ~J) )

(A.4)

Combining the expressions (A.3) and (A.4) for terms I and II of (A.I) produces

where (ij(S, t) is as previously defined in (2.4). By the definitions of Mf(s) and Mf(s), we
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I + II

=

~ {foc)Q (;j(S, t)dM;C(s) - 10

00

(ij(S, t)1[T; 2: s]

d[A~ - A~](S)} + op(n-I/2).
(A.5)

From Aalen's linear model and our choice of generalized inverse for the matrix A(t), we
have that for T; 2: s,

where X;(u),Xi(u),X(u),A(u), and MC(u) are as defined in the text. We then have that
(A.5) becomes

Finally, adding in expression (A.2) for term III, we arrive that

the desired martingale representation, thus completing the proof of Lemma IIA.

•
Proof of Theorem 111.1.

We first recall the martingale representation and predictable covariation process of

(A.6)
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Given the orthogonality [43] of the two terms of the martingale representation of the

hth component of Zj(t) in (A.6), we prove Theorem III.l by demonstrating the weak
convergence of each term to a normal limit. The first term,

(A.8)

directly corresponds to the martingale representation of K-sample test statistics for
counting processes as detailed in [6] (cf. Equation 5.2.3, p. 346). The conditions required
for weak convergence defined therein (cf. Theorem V.2.1, p. 360) are the existence of
deterministic functions

Y~j'

... 'YKj' yj'l/;j such that for all h, k, t

• 'l/;JY*)lj is integrable,
• n J~ W](s)Y,;'j(S)Ykj(S)(Y;(S))-l Aj(s)ds ~ J6 'l/;J(s)Yhis)Ykj(S)(Yj(s)t1 Aj(s)ds,
(convergence of the predictable covariation process to a continuous, deterministic
limit)

• nJ6 W](s)I [/y'nWj(s)/ >

E] Yj(s)Aj(s)ds ~ O.

(Lindeberg condition)

Under these assumptions, the conditions of the Rebelledo martingale central limit theorem
are satisfied, and the K-vector of terms (A.8) converges in distribution to a normal limit
with covariance defined by the first integral of (A. 7) [6].
We now consider the second term of (A.6) for the hth component of y'nZj(t),

(A.9)
Both ([ (s, t) and (j(s, t) in the definition of 'TI[ (s, t) are deterministic. Further, up to

op(n-l/2) terms, Yhj(t)

=

nhShj(t); hence, we write

We now make two assumptions regarding the asymptotic behavior of 'TI[ (s, t), in particular
imposing further conditions on the function 'l/;j defined above such that for all h,

• 'l/;j(U)Shj(U) (([(s,du) - (j(s,du)) is integrable with respect to u,
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• nh f~ Wj(U)Shj(U) ((f (s, du) - (j(s, du)) ~ f~ 'ljJj (U)Shj (U) ((f (S; du) - (j(s, du)),
Let 11f*(s, t) = f~ 'ljJj(U)Shj (u) ((f (s, du) - (j(s, du)).
We consider the (h, kyh component of the predictable covariation process for (A.9)
in two parts. The first term is nfooo 11f(s,t)TI>.(S)11f(s,t)ds, where I>.(s) is as defined in
(A. 7). Performing the multiplication produces

We assume that for all iand l

• ry{£* (s, t)2 Ali (s)

where the

ryf5*

is integrable

are the components of

11::*.

For the second term of (A.9), we assume the existence, finiteness, and
non-singularity of the matrix a(s)

y'ri .10

00

=

E [Xhi(S)X~(s)]. Then

11f (s, t)X(s)A -l(S )XT (s )dMC( s)
10 11:: (s, t)X(s)(n-

In
In 10
1

00

00

(00

v'n 10

11f (s, t)X(s)a-

1

1

A(S))-lXT(S)dMC(s)

(s)XT (s)dMC(s)

11f (s; t)P(s )dMC( s) + op(n-

+ op(n- 1/ 2 )

1 2
/ ),

where P(s) = plimn--+ooX(s)a- 1 (s)XT(s), which we assume to exist. The second term of
the (h, k)th component of the predictable covariation process for (A.9) is then
00

-n1100 11f (s, t)P(s )I>.(s )P(s )11f (s, t)ds.
We now assume that
00

-n1 10 11.f (s, t)P(s)I>.(s)P(s)11.f (s, t)ds ----. 10
p

0

0

Collecting our results thus far gives us that
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00

11.f*(s, t)P(s)l>. (s)P(s)11.f* (s, t)ds

10
10

00

TJf*(s, tfl>.(s)TJf*(s; t)ds00

TJf*(s, t)Tp(s)I>.(s)P(s)TJf*(s, t)ds,

(i.e.) that the predictable covariation process of Zj (t) approaches a deterministic limit.
We now make a general assumption to satisfy the Lindeberg condition of the
martingale central limit theorem for the second term (A.9) (the Lindeberg condition for
(A.8) has been addressed). Let

Hf (s, t) = Vn "If (s, t)T [I -

X(s)A -l(S)XT(s)], and note

that the second term of (A.6) can be expressed as

'.vhere H tfj (5, t) are the lexicographically ordered components of

Hf (s: t) We then assume

(cf. eq. 2.5.8, [6]) that

(i.e.) we assume that the second term (A.9) of the

hth

component of Zj(t) approaches a

continuous limit. This assumption, coupled with convergence of the predictable covariation
process to a deterministic limit, guarantees the convergence of (A.9) to a normal limit.
Putting the weak convergence of (A.8) and (A.9) while recognizing their orthogonality
proves Theorem 111.1.

•
Proof of Lemma. IV.1.

We begin by "vectorizing" the results from the proof of Theorem ILl. Specifically,

-

Theorem ILl asserts that Nij(t) = Nij(t) - Nij(t) fo~--'1
Ki(S)-ldMiC(s) and
~

}ij(t)

=

T*.+t- -

Y;j(t) - Y;j(t) fo'1

-

.

.

Ki(S)-ldMi(s). The correspondmg vector/matrIx results are
(A.IO)

diag {fij(t)} X(Tj

+ t) -

diag {Y;;(t)} X(T;

+ t)

diag {fij(t)} X(Tj

+ t) -

diag {Y;;(t)} X(T;

+ t) +

diag {fij(t)} X(T;
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+ t) -

diag {fij(t)} X(T; + t)

diag {fij(t) - ~;(t)} X(T;
diag {fij(t)} (X(Tj

+ t) +

+ t) - X(T; + t))

diag {fij(t) - ~;(t)} X(T;

+ t)

-diag

{~j(t) t)O 1[s < T;j + t]dMt(S)} X(Tj + t).

-diag

{l

10

OO

o

Ki(S)

} Y*(t)
_ 'J + t] dMiC(s)
Ki(S)
J

l[s < T*

(A.1l)

We note that the fourth line of the derivation of the result for Yj(t) - Yj(t) asserts that

diag { fij (t) } (X(T j

+ t) -

X(Tj

+ t))

is a zero matrix; we briefly illustrate this. The

(i, k)th element of this matrix expression is fij(t) (Xik(T;j

T;j

s: Gi , we note that T;j = T;j and hence Xik(T;j + t) =

element is zero. For T;j > Oi, Yij(t) = f[Uij - T;j 2': t, T;j

+ t) - Xik(T;j + t)).
Xik(T;j

+ t)

For

and the (i, k)th

s: Gd/ Ki(T;j + t-) = 0 and again

the (i, k)th element is zero. Therefore, diag {fij(t)} (X(Tj

+ t) -

X(Tj

+ t))

=

o.

Both (A.lO) and (A.1l) involve stochastic integration with respect to the function

dMHs). The equality dMiC(u) = dMiC(u) - 1[T; 2': u] d[Ai - Ai](u) noted in the proof of
Lemma 1I.4 takes vector form dMC(u) = dMC(u) - diag {1[T; 2': u]} d

[Ac - AC] (u).

By

Aalen's linear model for the censoring hazard, we have that

WhArp. YC(r) is as defined in the statement of the theorem. Therefore, we have that

dMC(u) = P(u)dMC(u), where P(u) is as in the statement of the theorem, and (A.IO) and
(A.II) become

(A.I2)

(A.I3)
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where DN(S) and Dy(s, t) are as in the statement of the theorem. We briefly note here the
product commutativity of symmetric matrices (such as P(u)) and diagonal matrices, which
will be used below. From (A.13), we note that a generalized inverse of Yj(t) is given by

and that a useful generalized inverse of 1 - Dy(s; t)P(u) is given by the matrix

(I + (I - Dy(s, t)P(u))-Dy(s, t)P(u)).
We now note that based on (A.12) and (A.13),

lot Yj(s)dNj(s) - Bj(t)
rt *- (
\~I
10 Y (s)\J+(I-.LJnu,s;.qu)j
T>

I

.\\-T>

j

(I - DN(u)P(u))dNj(s) - Bj(t)

I

\..-,.1

\ \

J.Jn"U,s)r~u)) x

+ op(n-l/2).

Expanding this expression produces

Bj(t) - Bj(t) =

lot Yj-(s)dNj(s) - Bj(t) +
lot Y;-(s) (I - Dy(u, s)P(u))- Dy(u, s)P(u)dNj(s) Ioty;-(s) (DN(U)P(U)

+ (I -

Dy(u,s)P(u))-Dy(u,s)P(u)x

DN(U)P(U)) dNj(s) + op(n-l/2).

(A.14)

Label the three summands of (A.14) as I, II, and III. By standard martingale methods (see
Eq. 7.4.7 of Andersen, et al [6]), the first term satisfies

(A.IS)

For term II, we note that the diagonal matrix Dy( u, s) and the symmetric matrix P (u)
commute, and that we can interchange the implied order of integration to produce

II =

io['XJ ior Yj-(s) (I -

_ . {f[U <K Tt + s] dNij(s)
*
}
P(u)dMC(u) +

Dy(u, s)P(u)) dIag

(:)

i

op(n- 1/ 2)

(A.16)
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Factoring the third term produces

which, after interchanging the order of integration implied by DN(U) and dNj(s) and
substituting in a simplified version of (I - Dy( u, s )P( u))-, becomes
III =

Putting (A.I6) and (A.17) together produces

II-III

=

J~C)C [J~tYj-(S)(1-DY(U,S)P(U))-diag{ (I[:~~ij]

*}] P(u)dM (u) +

f[u <Ki(U)
~j + sJ) dNij(s)

C

op(n -1/2 ),

lX) [l Yj-(s)(I - Dy(u, s)P(u))-diag{Q(u, s)}diag{dNj(s)}] x
P(u)dMC(u)

+ op(n- 1/ 2 ),

(A.I8)

Adding (A.I5) to (A.I8) produces

Bj(t) - Bj(t) =

l

Jj(s)Yj-(s)dM*(s) +
00

10 [lot Yj-(s)(1 P(u)dMC(u)

Dy(u, s)P(u))-diag{Q(u, s)}diag{ dNj(S)}] x

+ op(n- 1/ 2 ),

(A.19)

and the lemma is proven.

•
Proof of Theorem fV.2.

We recall the martingale representation of Bj(t) given above (A.I9) and its
predictable variation process:

(Bj(t) - Bj(t)) =

et
J

Jo

Jj(s)Yj-(s) diag{Aj(s)} Y;-(s)Tds+

00

10 [lot Yj-(s)(1 -

Dy(u, s)P(u))-diag{Q(u, s)}diag{ dNj(S)}] x
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P(u) diag{ ,\C( u)} p(uf

[lot Y;- (s)(1 -

Dy(u, s)P(u))- diag{Q(u, s)}

diag{dNj(s)}r du,

(A.20)

As with the proof of Theorem IlL I , we consider the two martingales composing

Bj (t) -

B j (t) separately given their orthogonality. We first note that the first term of

(A.19) directly corresponds to the martingale representation of Aalen's linear model for
counting processes as described in Andersen, et al [6] (d. Equation 7.4.7, pg. 564). The
conditions required for the weak convergence of this martingale are defined therein, which
we state here:
1. the existence of continuous functions Y)~2 (s), Y)~21 (s), and Y;~2Im (s), such that for all

O:S k,l,m:S pas n

--+ 00

• sUPsE[a,t]

I~ 2=~=1 Yj~ik(S) - Y)~2(s)1 ~ 0

• sUPsE[a,t]

I~ 2=~=1 1J:ik(S)Yj:il(s) - Y)~21(S)1 ~ 0

• sUPsE[a,t]

'~2=~1 Yj~ik(S)Yj:il(S)Yj:im(S) - Y;~2Im(s)1 ~ 0,

where Yj:kl denotes the (k, l)fh element of the matrix Yj;
2. for alll = 0, ... ,p,
1 2

n- /

3. the matrix

sup

SE[a,t]

k=l, ... ,n

IYj~kl(S)1 ~ 0;

yY) (s) = {Y)~21 (s) } is non-singular.

Under these conditions, the martingale yin

fJ J; (s )Yj- (s )dMj (s) defined in the first term

of (A.19) converges to a normal limit with covariance matrix defined by the first integral of
(A.20). The details of the proof can be found in the proof of Theorem VIl.4.1 in Andersen,
et al [6]. Note that although these conditions look somewhat esoteric, they directly
correspond to the conditions necessary for the application of the martingale central limit
theorem. Condition 1 establishes a law of large number for the products of the matrix
Yj(s) that form the least squares generalized inverse (Y;(s)TYj(S))-lYj(s)T, guaranteeing

their convergence to a continuous, deterministic limit which in turn guarantees the
convergence of the predictable covariation process to a continuous, deterministic limit.
Condition 2 is a Lindeberg condition on the elements of the covariate matrix

Y; (s), and

condition 3 guarantees that Y;(s)Ty;(S) converges to an invertible limit. Additional
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assumptions on the covariates generally lead to more explicit conditions for weak
convergence, such as assuming that the counting (N;j, Y;j) and covariate processes (Xi) are
together i.i.d. (see Andersen, et al [6], Ex. VIII.4.4 for further details).
We now turn attention to the second term of (A.19),

[f~ Y;-(s )(1 - Dy(u, s)P( ll)tdiag{ Q('tL s) }diag{ dNj(s)}] P(u)dMC(u).

Vn fooo

(A.21)
For notational convenience, let R( u, s)

=

(I - Dy (u, s )P( u)) By assumptions 1 and 3 on

the least squares generalized inverse of Y;(s) from the previous page, we note that

of Yj-(s)R(u, s).- diag{Q(u, s)}diag{ dNj(s)}
=

rt (n-lYj(s)TYj(S) r Yj(s)TR(u, s)-diag{Q(u, s)}diag{ dNj(s)}
n 10
2.n 10rt y)2)(S)-1 [Y (s)TR(ll,s)-diag{Q(u;s)}diag{dNj(s)}] + op(n-l/2)
~

1

j

where y;2) (s) is the matrix defined in condition 1 on the previous page. Performing the
stochastic integration implied above produces the (p + 1) x n matrix with (k, l)th element
(A.22)

generalized inverse of R( u, s), and yY2i (s) the (k, i)th element of y?). We now assume the
existence, finiteness, and continuity (in u) of the quantity
p

2: yY2i(Ut

j ·-

Tz'j)-l E [Ql(U, UiJ - Tz'j)Yhi(Utj - Tzj)Rhi(u, U1j - Tz'j)] ,

i=O

to which (A.22) converges via the law of large numbers. In summary, we have that the
inner integral of (A.21) converges to a (p + 1) x n matrix which we denote

~(u,

t).

We now turn attention to the matrix P(u). Since P(u) is a matrix product arising
from the estimation of the censoring hazard via Aalen's linear model, we can impose the
technical conditions previously used for Yj (s) onto YC( s):
cl

1. the existence of continuous functions Yh

for all 0 :::; h, k; l, m :::; p as n

)

- t 00
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(s), Yhc,;)(s), Yh~)(S), and Yh~~~(s) such that

•

SUPsE[O,t]

I~ L~l YS,(s) - y~c1)(S)1 ~ 0

•

SUPSE[O,t]

I~ L~=l y;,,(S)y;,,(S) - y~~2\S)1 ~

•

SUPSE[O,tj

I~ L~=l y;,,(S)Y;k(S)Y;[(S) - Y~~~\S)I ~ 0,

•

SUPsE[O,tj

I~ L~l y;,,(s)Y;k(s)Y;Hs)Y;~(s) - y~~~~(s)1 ~ 0,

0

where Yk1 denotes the (k, l)th element of the matrix YC;
2. for all l

=

0, ... ,p,

n- 1/ 2 sup

sE[O,t]

IYk1(s)1 ~ 0;

k=l, ... ,n

3. the matrix

y(c2) (s) =

{Yk~2) (s)} is non-singular.

We note that the fourth assumption for condition 1 is required since peu) involves a

4-product of the matrix Yc(u). These conditions ensure that P(u) approaches a
continuous, deterministic limit denoted p( u) as follows:

peu)

1- YcCu) (Yc(ufYc(U)

r

1

Yc(U)T

1- ;;1 Yc(u) ( n-lYc(u)Tyc(u)
1
n

1- - Yc(U)y(C2)(U)-lYc(u)T

)-1 Yc(u)T

+ op(n- 1/ 2 )

1- y(cl)(U)y(C2)(U)-ly(cl)(uf + op(n- 1/ 2 )

p(u)

+ op(n- 1/ 2 ).

We then have that the second term of the martingale representation (A.21) is

where we note that

~(u)p(u),

being continuous and deterministic, is predictable and hence

its stochastic integral with respect to the zero-mean martingale dMC(u) is also a zero-mean
martingale with variance given by the continuous, deterministic predictable covariation
process
(A.23)

to which the predictable covariation process (A.20) converges.
We make a general assumption to satisfy the Lindeberg condition required for
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asymptotic normality. Let H(u, t) denote the (p

H(u, t)

=

yin

[l y;-

+ 1)

x n matrix

(5 )(1 - Dy('ll: 5)P('ll)t diag{Q(u, 5)}diag{ dN;(s)}] P( u).

Then the second term of the martingale representation for Bj(t) - Bj(t) in (A.21) can be
expressed as foCXlH(u,t)dMC(u). The

kth

term of this vector is

We then assume (cf. eq. 2.5.8, [6]) that
(A.24)
for all k, (i.e.) we assume that each of the p + 1 components of the second term (A.21)
approaches a continuous limit (that the "jumps" of the associated martingale are
asymptotically arbitrarily small). The convergence of the predictable covariation process
(A.20) to a continuous, deterministic limit (A.23) coupled with Lindeberg condition (A.24)
ensures that the second term (A.21) in the martingale expansion of Bj(t) - Bj(t) converges
weakly to a normal limit. This result, coupled with the weak convergence of the first term
of (A.19) to a normal limit, while recognizing the orthogonality of the two terms of (A.19),
proves Theorem IV.2.

•
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